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ABSTRACT OF DISSERTATION

THE UTILITY OF ADHD-DIAGNOSTIC AND SYMPTOM VALIDITY MEASURES
IN THE ASSESSMENT OF UNDERGRADUATE STUDENT RESPONSE
DISTORTION: A CLINICALLY-ENHANCED SIMULATION STUDY
This study evaluated the efficacy of various attention-related, neuropsychological, and
symptom validity measures in the detection of feigned ADHD in an undergraduate
sample. Performance was compared between a group of presumed normal students
(HON), a group of diagnostically “clean” ADHD students asked to respond to the best of
their ability (ADHD), and a group of motivated, coached feigners (FGN). Feigners were
educated about symptoms and characteristics of ADHD, provided with a scenario to help
them relate to the plight of a student who might seek diagnosis, admonition to feign
believably, and a significant monetary incentive for “successful feigning” ($45). They
were not forewarned about the specific types of tests they would take nor alerted to the
presence of malingering detection instruments. Results illustrated that the ADHD
symptom-report measures, though sensitive to ADHD, were quite susceptible to faking.
The ARS and CAARS—S:L (using a stringent cut score of four or more scale elevations)
were successfully faked by 80% and 67% of students, respectively. The Conners CPT, in
contrast to those measures, had both limited sensitivity to ADHD and specificity for FGN
in this sample. Very high specificity and moderate sensitivity were noted for symptom
validity measures across the board, translating into high positive predictive values.
Binary logistic regression results indicate that the TOMM Trial 1 coupled with the DMT,
LMT, or NV-MSVT may be used to identify feigners with high predictive accuracy.
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Chapter One
Introduction
ADHD Overview
The most recent edition of the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV-TR, 2000) provides the presently-accepted nosology of psychiatric
and personality disorders that modern healthcare providers use for diagnosis. The
present edition characterizes Attention Deficit Hyperactivity Disorder (ADHD) as a
disorder first apparent in childhood; current diagnostic criteria require that
developmentally inappropriate symptoms of inattention or disinhibition, hyperactivity,
and impulsivity (depending on subtype) not only persist for at least 6 months, but have
been present since before the age of seven. Although that age was chosen somewhat
arbitrarily according to supporters and critics alike (Gordon & Murphy, 1998), it is
generally accepted that the problematic nature of these symptoms first emerges in the
early school years (see Barkley, 2006). Researchers theorize that the early onset is
attributable to a number of causes, including genetic neurodevelopmental or
organizational problems, or early structural damage to the fronto-subcortical circuit
(Powell & Voeller, 2004; Swanson & Castellanos, 2002) affecting appropriate acquisition
of essential cognitive, behavioral, and emotional regulatory behaviors. Numerous
structural and functional neuroimaging studies exist to support the presence of such
damage in diagnosed youngsters (see Dickstein, Bannon, Castellanos, & Milham [2006]
for a meta-analytic review of the literature). Of course, later ADHD onset is possible,
secondary to acquired neurological damage, but at this time there is no DSM-IV category
for this condition.
The Impact of ADHD in Educational Settings
Regardless of the specific cause or age of onset of attentional impairment, it is
clear that ADHD-characteristic dysfunction may be associated with significant
impairment in educational, occupational, and interpersonal functioning as a result of the
cognitive, behavioral, and emotional difficulties arising from ADHD. Thus, individuals
with the syndrome or disorder have the potential to be significantly disabled, requiring
special accommodations in educational settings. The myriad possible causes of such
impairment are reflected in substantial base rates of diagnosed ADHD—ranging from 7-
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12% of the elementary through high school-aged population, based upon an
epidemiological study conducted by the US Centers for Disease Control in 2003 (see
Biederman, 2005)—to estimates of 27% of adults, 1 including undiagnosed cases (see
Goldstein, 2006). Even at the more conservative estimates, which do not include those
young Americans for whom evaluation was out of reach due to economic, cultural,
parental, or other reasons, this leaves a great number who may require special
accommodations in their educational and occupational endeavors.
When tightening the focus of ADHD-affected individuals to college or university
students, it becomes even more difficult to cite a base rate with confidence. Evidence
exists that the syndrome may be "outgrown," and particularly that hyperactive symptoms
may remit (see Shaw, 2000, for a review; see also Biederman, Farone, Milberger, Curtis,
et al., 1996). However, prevalence estimates for adults with ADHD vary widely.
Barkley and Murphy (1998) estimated that 60% of childhood-onset patients experience
persistent ADHD. A meta-analytic review of the literature conducted by Farone,
Biederman, & Mick (2006), provides evidence that only 15% of individuals diagnosed in
childhood met full DSM-IV criteria by age 25, with 65% meeting criteria for ADHD "in
partial remission." Of note, these estimates do not include adult-onset cases lacking
evidence for the disorder in childhood, or "Adult ADHD," as it is termed in today's
media. In addition to statistical evidence for the resolution of some cases of ADHD,
biological and theoretical reasons for recovery can be derived from examination of the
acquired brain injury literature: Dendritic growth may occur, as evidenced in human and
other mammalian TBI and stroke research (see Chen, Atkins, Liu, Alonso, Dietrich, &
Hu, 2007 for an in-depth review; Scheff, Price, Hicks, Baldwin, Robinson, & Brackney,
2005), and individuals may develop compensatory strategies, as demonstrated in
cognitive rehabilitation literature (e.g., Yongue, 2006; Verne, Mezzanato, & Caminti,
2006; Mooney, Speed, & Shepard, 2005; Rath, Simon, Langenbahn, Sherr, & Diller,
2003). Moreover, the acquisition of the necessary cognitive, behavioral, and emotional
skills impaired in childhood-onset ADHD may be grossly slowed or delayed, rather than
thwarted altogether, for a portion of the affected.
1

This is an estimate based upon US Census data provided in wikipedia.org, using the estimated 8 million
adults referenced in Goldstein (2006). The estimate was derived from DSM-IV symptom telephone
surveys of 2.4 million US residents conducted by a Fortune-500 medical company (note conflict of
interest).
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Despite the challenges in establishing a reliable base rate of ADHD in collegeaged population, determining such is highly important for two reasons. First, it may
serve as a "check" for the integrity of an individual clinician's use of the diagnosis.
Second, it may serve as a signal for other phenomena, such as in the presence of
abnormally high local base rates or temporal increases in a base rate. For example, a rise
in current ADHD diagnoses from 2% to 20% of a university's medical school
population—a group for which high rates of lifelong impairment associated with ADHD
are unlikely—might indicate the growing popularity of seeking psychostimulant
medication. Indeed, a gross increase in the rate of adults, including college students,
seeking ADHD diagnostic evaluations has recently been evidenced (see Harrison, 2006).
Gordon and Murphy (1998) state that most institutions and testing organizations reported
at least a doubling of ADHD-based claims in the mid-to-late 1990s. Many of these
individuals were unable to provide adequate childhood histories or any evidence of
lifelong impairment (Harrison, 2006). This raises concern that an ADHD diagnosis is
being considered by at least some of these adult evaluees for the first time, and questions
as to why that may be direct attention to an issue of growing significance in university
settings.
Diagnostic Incentives in University Settings
Significant motivations and incentives exist for seeking a diagnosis of ADHD—
accurate or not—in North American higher education facilities. For one, the Americans
with Disabilities Act (ADA; 1990, PL 101-336) established that individuals with
cognitive and psychiatric disabilities, relative to the general population, may be eligible
for special accommodations. The ADA does not provide for otherwise unqualified
students to be granted an equal opportunity to those meeting the academic and technical
standards of a course or program (Keiser, 1998). Instead it calls for the establishment of
"Reasonable Accommodations."
Although a structured algorithm for the nature and degree of accommodations that
should be provided by educational facilities is not available, these typically involve
assistance "taking in the educational nourishment" (Keiser, 1998; p. 46) and receiving
fair evaluations, when applied to ADHD-diagnosed students (Keiser, 1998). McGuire
(1998) provides a list of common accommodations in such cases, which includes extra

3

time for written work and tests, no spelling penalty, selective seating, electronic aides
including tape recorders, reduced homework, availability of teacher notes, clarification of
directions and questions for assignments and exams when a student apparently does not
understand, and re-examination where re-teaching has been indicated. Because
pharmacotherapy is not considered an ADA accommodation despite the fact that it almost
always "wins" in head-to-head comparisons with non-medical interventions by producing
more positive effects in a shorter period of time (see Gordon & Murphy, 1998); and
because research has not indicated consistently efficacious environmental interventions
for ADHD students, meeting the ADA guideline of providing "Reasonable
Accommodations" for students with ADHD is difficult. Some universities have chosen
liberal approaches to this, perhaps to avoid legal ramifications. Both Harrison (2006) and
Jachimowiz and Geiselman (2004) give example accommodations, which extend far
beyond extra test time to include free computers, free tutoring services, private dormitory
rooms, and significant amounts of financial support. Separate testing rooms may also be
provided in many schools, and although this has not been stated outright, this may be
appealing to students inclined to cheat.
Jachimowiz and Geiselman (2004) comment that services and supports like those
described above are not only a great help to students with disabilities, but would be
equally helpful to those without disabilities. They further state that in today's job market,
enhancing college performance is helpful to secure employment or to improve chances of
attaining admission to graduate programs that may further increase odds of later career
and financial success. Based upon these notions, it is no surprise that undergraduates
may be consciously or unconsciously motivated to be diagnosed with ADHD. This is
only a part of the picture, however.
Beyond the ADA accommodations lies another potentially powerful incentive for
students to desire an ADHD diagnosis: psychostimulant medications. Just like steroids
may benefit the performance of most athletes, psychostimulants have the potential to
assist students regardless of the presence or absence of attentional dysfunction.
Stimulants work by enhancing catecholamine activity and probably by increasing the
availability of norepinephrine and dopamine at the synaptic cleft (see Solanto, 1998, in
Connor, 2006). The result is enhanced neurotransmission and a corresponding increase
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in blood flow to the frontal and parietal lobes. In turn, responders experience improved
attention and concentration, processing speed, and consequently better learning and
memory (see Connor, 2006, for a review of cognitive, learning, and academic
improvements). Stimulants may decrease required studying time, freeing more time for
socialization or other activities and result in better outcomes such as grades. They do not,
however, appear to significantly enhance performance on intellectual testing (Rapport &
Kelly, 1991, in Connor, 2006).
In addition to potentially improving academic functioning, psychostimulants may
be sought by students for recreational purposes. As with cocaine, prescription stimulants,
when inhaled or injected, cause a sense of euphoria. Mixing methylphenidate in
particular with large quantities of alcohol is said to enhance this euphoria while
diminishing the subjective sense of "drunkenness" (Barrett & Phil, 2002, in Harrison,
2006). Conti (2004) states that there is no better way to obtain a psychostimulant high
than legally, particularly when the prescription may be subsidized!
Evidence for both the recreational and academic misuse of prescription stimulants
is found throughout the literature. Several studies have reported a nation-wide increase in
psychostimulant prescriptions during recent years (see Olfson, 2003; Robison, 2002), and
multiple surveys have provided evidence of misuse at the university level. In a survey of
1,025 Northeastern US university students, 16% endorsed misuse or abuse of prescription
stimulants, with reported motivations of improving attention and grades (White, BeckerBlease, & Grace-Bishop, 2006). A survey of 10,904 randomly selected college students
identified a 6.7% prevalence of non-medical prescription stimulant use, 4.1% in the past
year, and 2.1% in the past month (McCabe, Knight, Teter, & Wechsler , 2005).
Likewise, an investigation of past-year illicit methylphenidate use in 2,250
undergraduates found a base rate of 3% (McCabe, Teter, Boyd, & Guthrie, 2003).
Identifying "Genuine" DSM-IV ADHD
Considering the information provided above, it becomes apparent that college
students have significant incentive to seek ADHD diagnosis and treatment, even when
they may know they do not require it. Unfortunately, little research exists today on how
best to identify genuine ADHD cases, while limiting misdiagnoses.
Arriving at a diagnosis of DSM-IV-defined ADHD is not simple. A sound
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determination requires ruling out multiple symptomatically similar conditions including
learning disabilities, psychiatric disorders such as anxiety, depression, bipolar disorder,
and early psychotic spectrum disorders—a process that involves conducting a very
detailed clinical interview, obtaining an adequate history with corroborating evidence,
and completing neuropsychological testing (see Gordon & Murphy, 1998). In addition,
diagnosis requires establishing that clinically significant levels of impairment are
currently present in social, academic, or occupational settings (see Hagar & Goldstein,
2005, for a discussion of "clinical significance" in undergraduate diagnoses); confirming
that evidence for impairment exists in at least two settings (such as home and class); and
perhaps most importantly, identifying evidence that impairment existed during childhood.
Lastly, when external incentives such as disability accommodations, studyenhancing medications, and stimulant "highs" are available, the possibility exists that
individuals without ADHD may deliberately try to be diagnosed (i.e., malinger) or subconsciously convince themselves (and in the process, others) of the disorder's presence.
If possible, clinicians should try to assess the legitimacy of symptoms, including selfpresentation on both subjective symptom reports and symptom-related test performance.
This directs attention to two caveats. First, the complexity of this evaluative
process is riddled with weaknesses in tests' diagnostic accuracies and abilities to predict
levels of impairment in everyday life. Unfortunately, there are no neuropsychological or
symptom report tests sensitive or specific enough to both ADHD and its rule-out
conditions to significantly facilitate this process (see Barkley, 2006; Gordon & Murphy,
1998). Computerized tests of impulsivity and attention have only fair sensitivity to the
condition (Homack & Reynolds, 2006), poor specificity to differentiate ADHD from
symptomatically similar conditions (Quinn, 2003; Homack & Reynolds, 2006), and poor
convergence with other measures (Homack & Reynolds, 2006). Self-report measures of
current or childhood symptoms are prone to over-identifying students and adults as
having ADHD when they do not—in addition to being insensitive to true ADHD
(Harrison, 2006; McCann & Roy-Byrne, 2006).
The second caveat is that very little empirical evidence exists as to the sensitivity
and susceptibility of self-report, standard neuropsychological, or feigning tools to
exaggerated or faked ADHD. The symptom-report measures and computerized
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continuous performance tests, including those with validity scales, have not routinely
been assessed for their robustness to faking. With one exception, stand-alone
neurocognitive feigning tools have not been evaluated in studies of feigned ADHD.
Instead, evaluations of neurocognitive feigning measures have most commonly been
conducted in genuinely and allegedly brain-injured samples claiming disability levels
warranting unemployment. It cannot be assumed that such measures will generalize to a
likely higher-functioning population such as that of college students claiming a relatively
partial disability. An evaluative review of the existing literature is provided below.
Previous Undergraduate ADHD Feigning Studies
At this time, only a handful of studies have evaluated one or more measures
employed in the diagnosis of ADHD, for susceptibility to feigning using a simulation
paradigm in an undergraduate sample. None of these are known-groups evaluations.
Table 1-1 provides a summary of each study's methodology, including demographic
makeup and specific instruction sets. Study results are provided in Table 1-2, in the form
of Hedges’ g effect size parameter, (a Cohen’s d equivalent corrected for small sample
size), and are discussed later.
Methodologies
As can be seen in Table 1-1, the few available studies identified lack consistency
in measures, research goal, and methodological rigor. Only three included an ADHDdiagnosed clinical control group. The majority of studies provided feigners with a
scenario that may help them relate to their role, information about the nature and
symptomatology of ADHD, and an admonition to feign believably. At face value, these
are strengths of the studies. However, no study with a clinical control group demonstrated diagnostic consistency, or more importantly, diagnostic certainty on an individual
level. For example, Quinn's (2003) ADHD group was "diagnosed" using only a clinical
interview and symptom report measure. Similarly, Harrison's (2007) clinical group was
identified using only a symptom-report measure and an achievement test. The Booksh
study (2005) ADHD group did not undergo a rule-out of psychiatric disorders that may
mimic ADHD. In addition to addressing these weaknesses, it can be argued that simple
procedures may be added to greatly enhance the ecological validity of ADHD feigning
studies. This is discussed in greater detail below.
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Table 1-1
Summary of Undergraduate ADHD Feigning Study Characteristics for those Involving a Simulation Group
M(SD)

First
Author

Study
Design

Grou
p

Recruit
From

N

Booksh

Sim

HON

PSY

54

Fisher

Othera

MAL

PSY

55

ADH
D

archive,
Univ
AC

56

MAL

PSY

88

8
87
Harrison

Jachimowitz

Sim

a

Other

HON

PSY

35

MAL

PSY

35

ADH
D

archive,
Univ
AC

72

MAL

PSY

20

Age

%
Male

20.4
(2.1)

20%

21.1
(3.1)

30%

19.6
(2.0)

18.7
(1.11)
22.9
(7.0)

-

M(SD)
IQ est

IQ
Source

comp/
inc

-

n/a

cc

-

n/a

cc, $50
raffle

-

n/a

n/a

n/a

cc, $25
raffle

NAART

cc

NAART

cc

WAIS-III

19%

-

36%

105.8
(6.6)
106.9
(6.5)

46%

-

106.7
(12.0)

-

n/a

8

mal
warn

scenario

Y

(1)

Y

(2)

Preparatory Procedures
and Measures
WAIS-III selections,
Connors' CPT,
WURS, MINI, WMT,
Rey FIT

Order of
Test
1. Effort
m 2. Rest,
randomized.

Some overlap with
above

Unknown

Read DSM-IV criteria
then asked to fake on
one measure: CARE or
ARS

Only one
test admin
to each
group

0

NAART; instructions;
then CAARS; WJ-III
Rdg Flu, Vis Matching
& Decision Speed
Met DSM-IV criteria
& Bush (2005) criteria
for symptom validity
assessment in absence
of formal assessmenta
CAARS, WAIS-III.

Unknown

cc

Read DSM-IV criteria
then asked to fake on
one measure: CAARS
WURS, BAAS or ARS

Only one
test admin
to each
group

Y

N

(3)

N

As listed

Leark

Quinn

Sim
w/in

H-M

PSY

18

M-H

PSY

Sim

HON

-

Y

-

Y

18

22.4
(2.4)

44%

-

n/a

PSY

19

-

-

-

n/a

-

MAL

PSY

23

-

-

-

n/a

-

ADH
D

Univ
DO

16

-

-

-

n/a

-

N

(4)

Coached. TOVA only.

(2)

IVA-CPT, BarkleyMurphy ADHD
Symptom Checklist
Interview, self-rpt,
some with IVA-CPT

n/a

Randomized
Unknown

Note. See Table 1-2 for a summary of applicable results. Where demographic cells are combined, this is merely how data were presented in the
study and does not imply that there was no group difference. cc = course credit, comp/inc = compensation or incentive, DP = differential
prevalence or correlational design (correlate test failure with performance on other measures), H-M = honest condition first then malingering
condition, m=measure, M-H=malingering condition first then honest condition, n/a=not applicable, PSY = Introductory Psychology course, Univ
AC = university assessment center, Univ DO = university Students with Disabilities Office, scenario=feigning scenario (listed below), warn =
admonition to feign believably, w/in = within subjects design.
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Feigning Scenarios:
(1) "Imagine that you have significant problems with inattention, impulsivity, and/or hyperactivity that are interfering with your academic
performance. You believe that if you are diagnosed with ADHD you may be given some academic accommodations, such as extended time for
tests, or medication, such as Ritalin, that will improve your grades. Your job in this experiment is to successfully convince the experimenter that
you have ADHD, so you want to perform on these tests as if you actually have ADHD. Some of the tests you will take contain validity measures
of effort and honesty that indicate whether you are putting forth good effort. You want to fool the experimenter, that is, you want it to look as if
you have ADHD, without arousing any suspicion. You should appear to be putting forth a good effort. Participants that successfully simulate
ADHD and have acceptable validity scores will be entered in a drawing at the end of the semester for a $50 gift certificate to a local restaurant."
(2) "Imagine yourself having trouble in school. Things aren't working out as you planned but your counselor's only advice is to work harder.
You want to get some help. You hear about adult ADHD on a television show. When talking to a friend about it, your friend tells you that you
could get special accommodations from the university, like untimed tests and rescheduling of exams if two are given on the same day. Your
friend ADHDs that the stimulant medications that are generally prescribed have minimal side effects and that you can take the medicine only
when you need it, just for school. You decide to read a book on ADHD. You find out that some ADHD adults even collect social security
benefits. You conclude that you have enough of the symptoms. You convince yourself that you have ADHD. You go to the doctor and you
really want to get help. In order to get these benefits, you need to convincingly act like a person who has ADHD."
(3) "We would like you to complete these tests as if you were pretending to have an attention deficit disorder (ADHD). Imagine that you have
heard about academic accommodations and other "perks" that are offered to people with this disability, and that you are trying to pretend that
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you have this condition. You have heard that people who have this diagnosis get extra time for tests and exams, and can access money to
purchase computers and other equipment. When you research ADHD on the internet, you find the following diagnostic criteria (see below)."
(DSM-IV criteria provided). "Please complete the following tests as if those characteristics apply to you. It is important, however, that you not
be caught in your efforts to exaggerate, so make sure your performance is believable."
(4) "I want you to take this test in such a way as to show me that you have ADHD when indeed you may not have ADHD. That is, try to make
yourself appear as if you have a problem with attention and impulse control, even though you do not. In other words, fake bad on the test, but try
not to be too obvious about your faking.
a

Only contained feigning participants, each group administered a different measure (N reflects group size).
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As a whole, the methodologies of the identified feigning studies do not begin to
compare in rigor to the research on feigned cognitive impairment (see Sollman & Berry,
under review, for a comparison). Methodological weaknesses include the fact that only
two studies reported providing simulators with incentive beyond course credit (Booksh,
2005; Fisher, 2007). Rogers (1997) cautions researchers that adequate incentives are
necessary in the assessment of simulated malingering in order to approximate real-world
conditions and to assure participants' motivation to feign. Additionally, only one study
utilized a number and variety of diagnostic tests that would approximate a real-world
evaluation, including standard neuropsychological measures (Booksh, 2005). Only one
study reported group IQ estimates, which are helpful for understanding the success of
feigning group and for comparing results between studies.
The most notable weakness in the evaluations is that only one study (Booksh,
2005) included a standard neurocognitive feigning measure. These are commonly
employed in evaluations of suspected or feigned neurocognitive impairment, which is
often associated with impulsivity and attentional difficulties that may mimic ADHD.
Theoretically, therefore, neurocognitive feigning measures may be helpful in the detection
of feigned ADHD. The Booksh study (2005) employed the Word Memory Test (Green,
2000), and found that it separated feigning and honest groups well (mean d-metric = 1.6)
and demonstrated superb specificity to rule out feigning in honest individuals (1.0).
However, the measure demonstrated only moderate sensitivity (.58). No studies
evaluated included psychiatric feigning indices which are frequently employed in
correctional and inpatient psychiatric settings.
Summary of Previous Studies’ Results
Having examined the methodologies of studies to date, a summary of the studies’
results ensues. These are provided for computerized measures of impulsivity and
attention (continuous performance tests [CPTs]), and symptom report tests in general.
Due to the number of measures examined and the differences in types of scores provided,
a quantitative summary of results across studies is generally not possible. However,
selected data are provided in Table 1-2.
CPTs. The Conners' CPT and the Integrated Visual and Auditory CPT (IVA-CPT)
were evaluated separately within two of the five above-mentioned ADHD feigning
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Table 1-2
Results of Previous Simulation Studies Pertinent to the Present Dissertation's Proposed Measures
Results (M [SD])

BOOKSH DISSERTATION (2005)
Connors' CPT
Commission Errors
Omission Errors
Hit Rate
Hit Rate Standard Error
Hit Rate Variability of Standard Error
12

FISHER DISSERTATION (2007)
Barkley-Murphy ARS
Current Symptoms
Inattentive Total
Hyperactive Total
Inattentive Symptoms
Inattentive Total
HARRISON (2007)
CAARS (see note below)
Inattention/Memory Problems
Hyperactivity/Restlessness
Impulsivity/Emotional Labiality
Problems with Self-Concept
DSM-IV Inattentive Symptoms
DSM-IV Hyperactive/Impulsive Sympt
DSM-IV ADHD Symptoms Total

Effect Size (g)

Test Parameters

HON

MAL

CLIN

HonClin

MalClin

HonMal

Sn

Sp

51.4 (11.2)
54.5 (10.7)
59.2 (13.5)
52.8 (10.3)

66.1 (13.5)
52.3 (15.1)
81.7 (25.1)
72.1 (16.9)

66.4 (14.7)
52.2 (10.4)
67.2 (14.7)
62.4 (11.6)

1.1
-0.2
0.6
0.9

0.1
0.0
0.7
0.7

1.2
0.2
1.1
1.4

n/a
n/a
n/a
n/a
n/a

n/a
n/a
n/a
n/a
n/a

n/a
n/a
n/a
n/a

77% faked
5.8 (2.4)
5.1(2.6)
11.0 (2.8)

n/a
n/a
n/a
n/a

n/a
n/a
n/a
n/a

n/a
n/a
n/a
n/a

n/a
n/a
n/a
n/a

-

n/a
n/a
n/a
n/a

-

-

-

1.2
1.4
0.8
0.7
1.5
1.1
1.4

0.4
0.8
0.8
0.3
0.7
1.3
1.1

-

-

-
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ADHD Index
JACHIMOWICZ & GEISELMAN (2004)
Barkley-Murphy ARS
CAARS—S:L
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QUINN (2003)
Barkley-Murphy ARS
Retrospective Symptoms
Inattentive Total
Hyperactive Total
Inattentive Symptoms
Hyperactive Symptoms
Current Symptoms
Inattentive Total
Hyperactive Total
Inattentive Symptoms
Hyperactive Symptoms

-

-

-

1.0

0.9

-

-

-

n/a
n/a

75% faked
90% faked

n/a
n/a

n/a
n/a

n/a
n/a

n/a
n/a

0.3
0.1

n/a
n/a

6.9 (5.2)
6.7 (5.1)
1.8 (2.5)
1.9 (2.1)

18.7 (5.6)
18.8 (6.1)
6.8 (2.5)
6.5 (2.4)

19.8 (4.4)
18.0 (5.3)
7.2 (1.7)
6.6 (2.2)

2.7
2.1
2.4
2.1

-.2
.1
-.2
-.0

2.1
2.1
2.0
2.0

4.9 (3.6)
5.3 (3.4)
0.7 (1.2)
0.8 (1.1)

17.9 (5.5)
15.5 (5.6)
6.4 (2.6)
5.4 (2.5)

14.7 (4.7)
14.4 (5.3)
4.9 (2.4)
4.8 (2.2)

2.3
2.0
2.2
2.2

.6
.2
.6
.3

2.7
2.1
2.7
2.3

.7a
.8
.7
n/a
n/a

.4 a
.6
.4
n/a
n/a

Note. In Harrison study, the MAL group obtained T- scores higher than the CLIN group on the CAARS. Raising the cut score to 70T created
more of a disparity between the three groups, and increased Specificity for the Hon group. Also, in the Harrison study, students were not
instructed to think of themselves "off of medications" when reporting on the CAARS. In the Quinn study, the ADHD group did not score in the
ADHD range on the Barkley Murphy ADHD Rating Scale's Current symptoms scale. Also, there was no significant difference between the
clinical and malingering group on Childhood symptoms scale; thus, malingerers were not discriminated. CLIN = clinical group, HON = honest
group, n/a = not applicable, MAL = feigning group, - = missing, Sn = sensitivity to actual ADHD, Sp = specificity.
a

Combined Subtype parameters: Using the criteria of >6 Inattentive items ranked 2 or 3, and > 6 Hyperactive items ranked 2 or 3. b Inattentive

Subtype parameters: Using the criteria of > 6 Inattentive items ranked 2 or 3. c Hyperactive Subtype parameters: Using the criteria of >5
Hyperactive symptoms ranked 2 or 3.
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studies. Both tests separated normal honest and ADHD groups on at least one index
(IVA-CPT Full Attention Quotient d-metric = 1.1 [Quinn, 2003], C-CPT Commission
Errors d-metric = 1.2 [Booksh, 2005]). The clinical group was accurately identified 86%
of the time in the Quinn study, using three different scoring algorithms. However, it must
be noted that this does not point to the measures' true sensitivity to ADHD, as other
diagnostic conditions were not ruled out in either study.
The separation of the feigning and ADHD groups across CPTs was less
successful. Only the IVA-CPT, as evaluated by Quinn (2003) appeared to be somewhat
resilient to feigning. The Full Attention Quotient of the IVA-CPT yielded a d-metric of
1.9, whereas the best C-CPT T-score mean yielded a d-metric of 0.7. The IVA-CPT was
not successfully faked on 81% of its scales according to the author. A mean sensitivity to
feigning of .86 was found for the IVA-CPT across three scoring algorithms.
Self-Report Symptom Questionnaires. Examining results across studies,
symptom report tests generally discriminated normal honest groups from both feigning
and ADHD groups. However, these measures demonstrated inadequacy in separating
feigned ADHD from diagnosed ADHD.
The Booksh (2005) study employed two symptom-report measures, the Wender
Utah Rating Scale (WURS) to assess historical (childhood) symptomatology, and the
Attention-Deficit Scale for Adults (ADSA) to assess current symptomatology. These
discriminated feigned and diagnosed ADHD profiles with variable success in this study
(WURS d-metric = .5, ADSA d-metric = 1.1). Test parameters could not be calculated
due to a lack of information. The Quinn (2003) study employed the Retrospective
(childhood) and Current Symptom indices of the Murphy and Barkley ADHD Rating
Scales. Neither of these robustly separated feigned from diagnosed ADHD profiles, with
d-metrics ranging from 0 to .6. Harrison (2007) examined the Conners Adult ADHD
Rating Scale (CAARS) and demonstrated slightly more promising results, effect size
estimates ranging from 0.3 to 1.2. Both the ADHD Total Symptoms Index (d –metric =
1.1) and the ADHD Hyperactive/Inattentive Symptoms Index (d-metric = 1.2) separated
simulated and diagnosed ADHD profiles somewhat adequately, in that study. Neither
Quinn (2003) nor Harrison (2007) provided data allowing for the calculation of test
parameters.
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Lastly, in the Jachimowicz and Geiselman (2004) study, students produced
profiles "consistent with ADHD" on the Brown ADHD Rating Scale in 95% of cases, on
the Conners ARS in 90% of cases, on the Barkley-Murphy ADHD rating scale in 75% of
cases, and on the Wender Utah in 65% of cases, after reading DSM-IV criteria. These
results, although consistent with literature examining the measures' abilities to separate
ADHD from other clinical profiles, are alarming. They highlight how little preparation
may be necessary in order to provide evidence of ADHD impairment. In light of this
"internet age," where vast amounts of information are available to read and "to go" at the
click of a button, these data are even more concerning.
Summary and Statement of the Problem
There is no question that significant incentives exist for college students to seek
ADHD diagnoses regardless of whether or not they believe they genuinely have the
disorder. The recently-growing base rates of ADHD diagnostic evaluations and treatment
prescriptions, discussed above, suggest that this is an area requiring attention.
Unfortunately, it is also apparent that existing diagnostic procedures are weak at
distinguishing ADHD from other clinical disorders, and very little information is available
regarding their robustness to feigning.
Before researchers can make accurate claims about measures' abilities to separate
ADHD from other clinical conditions, it is necessary to understand how successful such
tests are at ruling out feigned inattention. Thus, significantly more evaluations of the
symptom self-report, computerized impulsivity / inattention measures, objective feigning
measures, and even standard neuropsychological tests need to be undertaken. In order to
generalize results of such research to a college population, it is necessary to conduct such
work within relevant samples.
It is not enough to simply conduct analog evaluations of the various tests with a
clinical comparison group, however. In order to develop sound predictions of how well
results will hold up in the real world, it is necessary to conduct research that is as
ecologically valid as possible. Educated individuals intent on receiving a diagnosis of
ADHD will likely not just arrive for an evaluation unprepared, in hopes of "getting
lucky." Minimally, they will probably educate themselves about the disorder. This can
be done with very little effort today, thanks to the Internet. Unfortunately, the ecological

15

validity of the existing studies described above has been an obvious weakness.
Goals of the Present Study
The present study investigates whether various well-validated ADHD-related,
standard neuropsychological, and symptom validity measures previously studied in other
populations may be extended to an undergraduate ADHD-diagnostic setting where
feigning may occur. The measures’ abilities to separate actual and feigned ADHD
groups, and to accurately classify individuals as clinical or not, will be evaluated. In
order to produce the most ecologically valid results, the methodological focus will be on
adequately motivating and preparing feigners for their role. Preparation will involve
providing information obtained directly from the internet to students, and allowing them
time to process this information and develop a "plan of action." Motivation will come in
the form of financial incentive for “successful” feigning. In order to provide results that
are practical for clinicians, measures will be selected based upon their popularity and
economic appeal (for cost and time) in clinical practice, in addition to their previously
identified psychometric strengths in either ADHD or other neuropsychological domains.

Copyright © Myriam J. Sollman 2008
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Chapter Two: Method
Participants
Participants were eighty undergraduates at the University of Kentucky. Two
groups were sought: students without ADHD (“Presumed Normals”) and students with a
previous, verifiable diagnosis of ADHD. Presumed Normals were screened to rule out
any comorbid disorder that presents similarly to attention/concentration difficulty,
including learning disabilities, diagnosed or self-perceived psychiatric conditions,
neurological disorders, and a history of head injury. A diagnostically “clean” ADHD
group was also sought, and those with comorbid neuropsychological, neurological, and
psychiatric conditions were excluded. ADHD referrals were additionally asked what
types of procedures they underwent for diagnosis (neuropsychological testing, symptom
self-report, parent interview, classroom observation, teacher rating, et cetera) to
maximize diagnostic integrity. Students reportedly diagnosed in a brief office visit or
using only symptom report were excluded.
Both Presumed Normal and ADHD participants were recruited via the University
of Kentucky Introductory Psychology class Mass Screening Session. This is a nonrequired class period where students interested in fulfilling a research exposure
requirement by participating in research studies, rather than reviewing journal articles,
anonymously fill out multiple pre-screening questionnaires. The questionnaire used in
this study is provided in Appendix A, and examines the above-mentioned diagnostic
characteristics. This questionnaire served to identify both prospective Presumed Normals
and some ADHD participants.
ADHD participants were identified in several ways. As noted, some were initially
selected using results from the mass screening. Additional ADHD participants responded
to a flier (Appendix B) either posted in the University Disability Office (UDO) or
emailed to ADHD-diagnosed students registered there. All ADHD-diagnosed students
were asked if they were registered with the UDO as having ADHD, or could provide
proof of their diagnosis at the time of participation, before being selected as a participant.
Procedure
Either a senior research assistant (identifying herself by first name and affiliation),
or the primary investigator contacted eligible Presumed Normals identified from the
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subject pool to screen them further (Appendices C-D). Those who continued to meet the
previously described criteria were scheduled for participation. The primary investigator
of this study contacted all eligible ADHD participants for full screening, in order to
maximize confidentiality. ADHD participants were told that they would be contacted at a
later date if they met inclusion criteria, which additionally included willingness to skip
their medication for a twelve-hour wash-out period prior to testing. This was done so as
not to give away inclusion criteria. Those qualifying were subsequently phoned by the
same individual, told of the medication requirement, and asked again if they would like to
participate. Scheduling was arranged to be at the safest and most convenient time for that
student, in light of this. Subjects were called twenty-four hours before participation with
a reminder of the appointment and medication requirement. Because of this
methodology, and reimbursement requirements, the primary investigator was not blind to
participants’ clinical status.
As compensation and incentive for participation, Presumed Normals were told
they would receive two research credits (of their required six) at testing completion. (In
reality, some participants received greater incentive, as described later). ADHD
participants were offered a choice of two research credits and $15 (for medication-related
inconveniences), or $45 and no research credits. So, ADHD participants not enrolled in
Introductory Psychology always got $45, as research credits were not useful for them.
Presumed Normal participants were tested using two examiners, where one
(RA1) provided pretesting and preparation protocol, and another, blind examiner
completed the testing battery (RA2). RA1 obtained informed consent and administered a
demographic and diagnostic questionnaire (Appendix E) as well as a “word reading test”
for IQ estimation (Wechsler Test of Adult Reading [WTAR; Wechsler, 2001]). RA1
then provided information about the study and the procedures to come. To maintain
confidentiality and give students a chance to recall any diagnoses they neglected to tell
the phone screener, the demographic questionnaire was completed in privacy and sealed
in an envelope by the evaluee.
After being informed about the nature of this study, Presumed Normal students
were randomly assigned to an Honest (HON) or Feigning (FGN) condition by selecting
from two envelopes with enclosed role-specific information. RA1 instructed participants
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not to disclose their role to RA2, who would be testing them.
Students in the HON condition received an explanation of the purpose and
importance of a normal control group, and were asked to take the tests to the best of their
ability. They were then asked to remain in the testing room for a few minutes, until RA2
was ready. FGN-condition students were congratulated with excitement in order to
increase their attention, involvement and motivation; they were then told that if they
were “successful” in that assignment, they would receive $45 in addition to the two
research credits already offered. They were then provided with a feigning scenario (see
below), followed by information about ADHD. This information was obtained from the
first few listed Google “hits” for ADHD and ADHD diagnosis (Appendix F) at the time
of study inception, Fall 2006. FGN-role individuals were then given instruction to take
five minutes to read through the scenario and internet information (presented in a pseudo
web-page format), and to take notes. Prior to reading, they were encouraged to think
about how this information would relate to their presentation in a testing evaluation.
Feigning Scenario:
Your roommate has been diagnosed with ADHD. S/he had trouble with classes, but
then was given some medication for ADHD, and now does well. S/he even got a
couple of A's recently, and has more time to socialize because studying is not as
hard! During your midterms, you decided to try your roommate's medication, and
ended up surprising yourself with how much easier things went. You may think that
you have undiagnosed ADHD, so you "Google" the disorder to learn more about it.
On the following pages are some of the things that you find.
When you are done reviewing these materials, please use the colored paper to jot
down symptoms that will help you remember how to fake on the tests you will be
given. Tell the examiner when you are done.

After their five-minute preparation, FGN students were asked to describe symptoms
of ADHD and to share how this disorder may affect testing results. They were then told
to remember that they are “presenting” as a university student, so must do at least as well
as someone who would be admitted to the University of Kentucky. They were cautioned
not to reveal their role or to feign too blatantly lest they lose the $45 incentive. (In
reality, however, all FGN students received the $45 incentive due to Internal Review
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Board guidelines.) Students who appeared inadequately prepared were asked leading
questions about symptoms, such as, “How would someone with ADHD pay attention to a
lecture?” They were not ‘coached to the tests’ through information that symptom validity
measures were imbedded or through instruction about what symptoms to fake on certain
types of tasks. FGN-role participants were then given the post-preparation instructions
below, by RA1, reminding them of cautions and incentives.
Post-Preparation Instructions:
You will now be introduced to the person who will complete testing with you.
Please take the following tests as if you are trying to convince someone that you
have ADHD. It is not necessary for you to try to act like you have ADHD; you
only need to respond to the test items as if you do. The examiner who tests you will
not know your role, so please do not give it away!
Remember, if you are successful at deceiving the tests and following instructions
throughout, you can win $45!
If you have any questions, please take time to ask me right now.

Students in the ADHD condition (ADHD) were all tested by the primary
investigator. All participants were debriefed (Appendix G) and provided a manipulation
check (Appendix H) to determine if they understood what they were asked to do and
complied with their instructions. Students were then compensated for their participation.
Materials
Pretesting Measures
Pretesting measures included the demographic questionnaire (Appendix E) and
the WTAR (described below).
Wechsler Test of Adult Reading (WTAR; Wechsler, 2001)
The WTAR is a word-reading test for individuals aged 16-89 that utilizes
atypically-pronounced (i.e., nonphonetic) words. It is used to estimate intelligence level,
or premorbid intelligence level when damage-related declined is suspected, because
reading recognition is relatively stable in the presence of brain insult (though not immune
to effects of notable intellectual impairment [see Spreen & Strauss, 1998; Putnam,
Ricker, Ross, & Kurtz, 1999 for reviews, as provided in test manual]). For this purpose,
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it was selected for inclusion in order to evaluate HON, FGN, and ADHD groups’
intellectual equivalence.
The WTAR's US Standardization sample was a nationally-representative,
stratified sample of 1,134 adolescents and adults aged 16-89. Target values for
stratification closely matched 1995 US Census data for age, gender, race/ethnicity,
education, and geographic region. However, standard normative data are provided by
gender, age (16-17, 18-19, 20-24, 25-29, etc.), and ethnicity.
The WTAR displayed excellent internal consistency (alpha = .90 to .92 for ages
18—34). Standard errors of measurement were relatively adequate (+ 8.1 to 9.5 points at
95% Confidence Interval for ages 16—34), and excellent test-retest reliability for a mean
inter-test interval of 35 days (corrected r = .92 for adults aged 18—29). It also
demonstrated very good convergence with the AMNART, as evidenced by a mean
correlation of .90. Moderate correlations between the WTAR and the WAIS-III Verbal
IQ were demonstrated by the standardization sample, ranging from .74 (age 18-19) to .79
(age 20-24) for college-aged adults. Similar correlations were found with the Full Scale
IQ (.70 for age 18-19 and .74 for age 20-24), though the WTAR tends to predict the VIQ
slightly better than the FSIQ in all age groups. Thus, the WTAR appears to be a fairly
good source of Verbal IQ estimation. Further, data presented in the manual suggest it is
a good indicator of IQ for ADHD evaluees as well.
Materials for Remainder of Protocol
Tests administered by RA2 after the pretest and preparation period included
ADHD-related measures, symptom validity tests, and neuropsychological measures.
These were given in a counter-balanced fashion, with one of the symptom validity tests
always administered first.
ADHD-Related Measures. Two ADHD symptom report measures (the Murphy &
Barkley ADHD Rating Scale [ARS], Current Symptoms and Childhood Symptoms
subscales; the Conners’ Adult ADHD Rating Scale—Self Report, Long Version
[CAARS—S:L]), and a computerized continuous performance task (the Conners’
Continuous Performance Test [CPT]) were administered. The ADHD group participants
were asked to complete the symptom-report measures with regard to how they currently
felt when unmedicated, so that results would provide their clinical profile.
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ADHD Rating Scale (ARS): Current & Childhood Symptom Checklists (ARS)
These indices, first published by Kevin Murphy and Russell Barkley in 1996, are
commonly used in the assessment of ADHD for individuals over the age of 12. The ARS
Current and Childhood Symptoms scales were constructed using the 18-item DSM-IV
symptom list. Evaluees are asked to rate the extent to which they have been experiencing
various symptoms within the past 6 months (Current Symptoms Checklist), and from age
5-12 (Childhood Symptoms Checklist), using a Likert scale that ranges from 0 ("Never or
rarely") to 3 ("Very often"). Nine Inattention items are alternated with nine Hyperactivity
items on each index. The forms are hand scored, and each completed index produces
three "Symptom Count" scores on both the Childhood and Current Symptoms indices.
The Inattentive and Hyperactive symptom counts are the sum of their relevant items rated
"2" or "3." A Total ADHD Scale for Childhood and Hyperactive symptoms is the
summation of the two counts. Murphy and Barkley (1996) provide norms for the
population of interest; these are also recommended in Barkley, Murphy, & Fisher (2008).
The authors recommend that both Current and Childhood criteria are met to fulfill DSMIV criteria. In the developmental sample, consisting of individuals applying for or
renewing Massachusetts driver's licenses, no gender effects were demonstrated for
Current symptoms. Childhood ratings produced greater symptom endorsements by males.
As discussed in the introduction, susceptibility of the ARS to feigning has been
investigated in three studies, only one of which was a simulation design, however (see
Tables 1-1 and 1-2). In Quinn’s (2003) simulation study, and Jachimowicz &
Geiselman’s (2004) and Fisher’s (2007) quasi-experimental evaluations, the measure was
successfully faked. Quinn (2003) reported small effect sizes (g) for both Current (M =
0.4) and Childhood (M = 0.0) symptoms in comparing feigned and ADHD student
profiles; Jachimowicz and Geiselman (2004) stated that ADHD profiles were obtained by
75% of feigners; and Fisher (2007) reported successful faking by 77% of undergraduate
feigners. Though these rates seem alarming, the latter two studies provided evidence that
the ARS was significantly less susceptible to feigning than other tests examined, which
were falsified by up to 95% of feigners.
Thus, the ARS was selected for inclusion for its potentially greater resilience, as
well as due to its common use and economics—usage is free and unlimited to examiners
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who purchase the book. As with the CAARS—S:L (described below), the ARS was
derived directly from DSM-IV diagnostic criteria. Thus, it has the potential to have
either strong convergence, or redundancy (a weakness), with the CAARS—S:L.
However, the ARS adds information about childhood symptoms, which is required by the
DSM-IV for diagnosis. Moreover, because symptom scales are indicated only for the
support of diagnostic decisions, and because two current symptom indices are not likely
given within the same evaluation, the impact of such redundancy is limited.
Conners’ Adult ADHD Rating Scale, Self-Rating Form, Long (CAARS-S:L)
This measure (Conners, Erhardt, & Sparrow, 1999) is commonly used in the
assessment of ADHD with individuals 18 and older. The CAARS—S:L has adult
evaluees rate the extent to which they have "recently" been experiencing various
symptoms of ADHD on a 4-point Likert scale ranging from 0 ("Not at all, Never") to 3
("Very much, very frequently"). Responses are hand-scored on the carbon-write form as
indicated by specific instructions, and presented as age and gender-stratified T-scores
arranged on 8 subscales and an Inconsistency Index. T-scores greater than 65 correspond
to a "clinical elevation."
The eight subscales of the CAARS—S:L include four DSM-IV-derived
"diagnostic" indices, four factor-derived subscales, and an Inconsistency Index. The
latter index, generally examined first, estimates whether the pattern of responses is
consistent across items, and is calculated by finding the sum of absolute differences
between eight highly correlated item pairs. Cutoff scores indicative of inconsistency
were derived by comparing profiles of 100 respondents from 100 computer-generated
(random) profiles, which resulted in 96% sensitivity and 96% specificity. This Index
increases the clinical appeal of the CAARS—S:L.
After examining the Inconsistency Index, clinicians are urged to consider the
diagnostic indices, with T-scores above 65 being clinically significant. The diagnostic
indices first include the ADHD Index (“Scale 8”), which is a summary score reflecting
whether the evaluee has clinically significant levels of ADHD symptoms compared to
other adults. Scale 8 is said to differentiate clinical from non-clinical levels of ADHD
symptomatology, and to be the best screen for identifying "at risk" individuals (see test
manual). Next, the DSM-IV Inattentive Symptoms subscale (“Scale 5”) provides an

23

indication of whether the rater has clinically significant levels of inattention,
corresponding to the current diagnostic criteria. It contains nine items and is based
directly upon the nine inattentive symptoms provided in the Diagnostic manual. The
DSM-IV Hyperactive-Impulsive subscale (“Scale 6”) provides the same information for
the alternative diagnostic subtype, also including nine items corresponding directly to
those in the DSM-IV. Finally, the DSM-IV Total ADHD Symptoms subscale (“Scale 7”)
indicates whether the individual meets criteria for ADHD according to the DSM-IV; it is
based upon the sum of the two preceding subscales.
After considering the diagnostic indices, the clinician may turn to the factorderived subscales for more information regarding the evaluee's specific areas of
difficulty. These include the Inattention/Memory Problems scale (with high scores
corresponding to slower learning, organizational difficulty, and trouble completing tasks
and concentrating), the Hyperactivity/ Restlessness scale (with high scores reflecting
difficulty working on one task for prolonged periods as well as greater feelings of
restlessness than others), the Impulsivity/Emotional Liability (reflecting impulsive
behavior, sudden mood changes, and quicker anger and irritation than others), and lastly
the Problems with Self-Concept (which reflects poor social relationships, low selfesteem, and low self-confidence).
Although the diagnostic subscales are generally examined first, CAARS—S:L
scores are generally interpreted in light of the number of clinically-elevated subscales (at
T > 65). If only one elevation is present, the pattern of symptoms is said to be
"marginal."
The CAARS—S:L was developed from an original item pool of 93 statements,
administered to 839 nonclinical adults. Factor analysis revealed 66 items on four factors,
accounting for 46.8% of the total variance. The normative sample consisted of 1,026
adults. A satisfactory mean inter-item correlation was demonstrated for each scale
(excluding the Inconsistency Index). Moderately high mean test-retest reliability was
found (.91), suggesting that the measure is only mildly susceptible to temporal
variability. Good validity characteristics were also demonstrated. As with the ARS, the
CAARS:S—L does not appear to have been cross-validated with other ADHD current
symptom scales. An evaluation of its convergence with the Wender Utah Rating Scale,
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an assessment of childhood symptoms, demonstrated only moderate correlations (.37—
.67; see Macey, 2003). Discriminant validity was demonstrated using DSM-IV
diagnosed adults (Erhardt et al., 1999). The ADHD Index in particular demonstrated a
sensitivity of .71 and a specificity of .75 in a cross-validation involving 192 adults.
Susceptibility of the CAARS to falsification has only been evaluated by
Jachimowicz and Geiselman (2004), as described above, where 90% of college students
asked to read DSM-IV criteria were able to create ADHD-like profiles. Additional
weaknesses of this index include marginal correlations between Self and Observer (Long)
ratings for both males and females (Range = .42 to .61 for men, .45 to .61 for women),
administration length, and the absence of a childhood symptom evaluation, as stated
above. The measure's psychometrics for use with ethnic or racial minority evaluees have
been poorly examined, and the test manual does not provide the normative composition
of such groups (Macey, 2003).
Despite flaws, the CAARS—S:L was selected for inclusion in this study for
several reasons beyond the appeal of its Inconsistency Index. The CAARS was
developed by one of the foremost researchers of ADHD, and been relatively wellvalidated. Self-report measures of ADHD symptomatology should be of great interest in
ADHD feigning research, as they are very commonly used in ADHD diagnostic
evaluations. Such measures provide a great deal of information while requiring very little
clinician time. Research shows that many health care providers, particularly primary care
providers, use these to arrive at a diagnosis (Eliott, 2002, as cited in McCann & RoyByrne, 2004). For these reasons, obtaining an indication of the measure's vulnerability to
exaggerated or feigned responses should be of great interest.
Conners' Continuous Performance Test (CPT)—II for Windows
The Conners' CPT (C-CPT hereafter; Conners, 2000) is one of several
computerized tests commonly used to screen for problems that may be associated with
ADHD, including impulsivity and inattention. It measures sustained visual attention,
response inhibition, and response rate.
In the C-CPT, evaluees are asked to hit the spacebar every time they see a letter
other than "X" on the screen. Letters are flashed in one location, one at a time at variable
intervals for 15 minutes. The C-CPT is scored in terms of errors of omission (missing
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targets) and commission (responding to non-targets), hit reaction time, hit reaction time
standard error, and variability of standard error, among other factors. Failure to respond
to target stimuli is considered an indication of inattention, while responding to non-target
stimuli is considered a reflection of impulsivity or motoric disinhibition. Both are
traditional indicators of ADHD, although the extent to which they are manifested is
thought to vary with diagnostic subtype (Homack & Reynolds, 2006). With regard to
the utility of hit reaction time, evidence has been conflicting. The construct has typically
been labeled an indication of "processing efficiency." However, several factors,
including motivation, may effect response time, and more recent literature has suggested
that ADHD evaluees have "normal" reaction times, on average (see Hervey, Epstein, and
Curry, 2004). Instead, the standard error for response time may be considered as an
indication of the variability of "attentiveness."
CPTs are generally similar in that evaluees are asked to respond to some stimuli
while ignoring others for a prolonged period of time, with variable target presentation
frequency. Conners' version differs from others in that it has a large number of target
stimuli embedded in a small number of non-target stimuli, rather than the reverse. Thus,
it should theoretically tap disinhibition for non-target stimuli (i.e., commission errors)
better than the other measures. Literature has shown that the measures with a low number
of target stimuli discriminate omission errors better than the C-CPT (see a meta-analytic
review by Hervey et al., 2004). In addition to omission and commission error scores, the
C-CPT provides a hit reaction time, standard error, and a standard error variability score.
A T- score of 60 or greater on any C-CPT index is said to be a high probability marker of
attentional problems (Conners, 2000).
Conners' CPT was developed and normed using more than 2000 individuals. Of
those aged 18-34, however, only 237 were non-clinical and only 48 had a diagnosis of
ADHD. No age effects were found in the adult samples. Adult gender effects may be
observed for commission errors. Overall, a high split-half reliability was found for hit
reaction time (.95), omissions (.94), standard error (.87), and commissions (.83), with
variability (.66) lagging. Moderate test-retest reliability was noted across these indices,
ranging from .84 for omissions to .60 for variability. Results of validity assessments
suggest that the above indices generally discriminated the clinical (ADHD and
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neurological) and non-clinical adult normative groups, despite the relatively small sample
sizes. Likewise, a multi-site study of 107 ADHD cases, 223 neurologically impaired, and
437 non-clinical cases provided in the manual resulted in a high sensitivity for ADHD
(88%) and neurological patients (85%); with a moderate specificity for non-ADHD
(87%) and non-neurological (92%) patients. Looking specifically at the ADHD versus
normal control normative data, ADHD individuals performed statistically significantly
worse on all indicators. However, these data were derived from "pure" contrasts of
ADHD patients vs. normals, or neurological patients vs. the same normals, so the
diagnostic accuracy of an ADHD vs. neurological group is unknown. Also, this finding
is challenged by another study suggesting that the C-CPT was unable to discriminate
ADHD and normal control adolescents (Homack & Riccio, 2005).
Although the above data are somewhat encouraging, further evaluation is needed,
particularly with mixed clinical groups. Other studies have demonstrated that the C-CPT
is insensitive to differences between ADHD and PTSD (Schmitt, 2000) in addition to
other anxiety disorders, depression, and Cluster A personality traits (see Homack &
Reynolds, 2006). An evaluation of the measure's convergence with ADHD rating scales
in adults diagnosed only with ADHD demonstrated a lack of correlation between results,
though restriction of range may have been an issue (Epstein, Conners, Sitarenios, &
Erhardt, 1998). Performance has also been shown to be affected by anxiety (see test
manual; Schweiger et al., 2007). The general consensus is that CPTs only provide
information about the presence of symptoms of disorders involving attention problems
and impulsivity, rather than information about the presence of a specific disorder
(Homack & Reynolds, 2006). Not surprisingly then, the C-CPT is indicated only for use
as a screen for the presence of attention-related problems.
Despite weaknesses and limitations, the C-CPT was chosen for inclusion in this
study because its susceptibility to feigned dysfunction requires further evaluation.
Booksh (2005) demonstrated a lack of separation between simulated and diagnosed
ADHD groups on C-CPT indices, using a college sample (g range = 0 to 0.7). However,
the same study also obtained high g’s of 1.4 (for Hit Rate Variability of Standard Error)
and 1.1 (for Commission Errors) in the separation of normal honest and ADHDdiagnosed students, as well as a high g of 1.1 (for Commission Errors) in the separation
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of the normal honest and feigning groups, pointing to its potential. These results contrast
with an undergraduate simulation study of the IVA-CPT (which includes auditory and
visual stimuli); this study found that the IVA was "not fakable" on more than 80% of its
scales (Quinn, 2003). Across three different impairment indices, a mean sensitivity to
feigning of .85 and a mean specificity of .85 were found. Looking specifically at the full
scale indices using the Response Control and Attention Quotient published cutoffs,
sensitivity was .81 and specificity was .91. This contrast from C-CPT results provides
interest in replicating the Booksh evaluation.
Standard Neuropsychological Measures
Several neuropsychological tests were included to increase the ecological and face
validity of the test protocol as a neuropsychological battery. Unlike the symptoms
reports and C-CPT, these measures do not assess ADHD in such a transparent way. Also,
they detract attention from the malingering tests described below.
Stroop Color-Word Test
Several version of the Stroop measure exist, but the variant selected for this
study, the Charles Golden version (Golden, 1978; Golden & Freshwater, 1999) was one
commonly used in neuropsychological practices. In this version, evaluees first read
aloud a list of color names as quickly as possible, for 45 seconds ("Word" subtest). Then,
the ink color that "XXXX" is printed in is stated for 45 seconds ("Color" subtest). Lastly,
the ink color used to print various incongruous color names is named for 45 seconds
("Color-Word" subtest). In each trial, errors are identified and the evaluee must correct
them before going on. The total number of correct items and the total number of errors
are indicated in the score of each trial. The test manual recommends that subtest raw
scores first be converted to an age and education-corrected T-score using equations
provided in the manual. These corrections were derived from the prediction of "normal"
performance using an updated normative sample. Following calculation of T-scores, the
"Interference Score" is calculated using the raw Color and Word scores. This score is
said to represent the ability of an individual to inhibit word naming when reading ink
color in the Color-Word subtest, and was originally based upon the amount of time to
read one Word item followed by one Color item (45/total Word + 45/total Color), which
would translate to CW= (W*C) / (W + C) when considering the number of items that
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should be completed on the Color-Word subtest. Although all scores are corrected for
age and education only, several studies have demonstrated gender effects for reading the
Color page, although not the Color-Word page in college students (Jensen, 1965; Stroop,
1935; Brown, 1915), as well as younger individuals. This needs to be considered when
examining results of the present study. Additional considerations are provided below.
Hervey, Epstein, and Curry (2004) conducted a meta-analytic review of 33
published studies contrasting performance of ADHD and "normal" adults on various
neuropsychological measures. Seven studies evaluated the Color-Word difference score
in the Golden version, and found a mean g of .47, suggesting that this index is moderately
effective at discriminating ADHD and non-ADHD adults. For the Golden-derived
interference score, however, the g was just .19, suggesting that this does not effectively
discriminate these groups. The review had several major limitations, though, most
notably uncertain criterion status due to inconsistent diagnostic criteria and assessment
procedures. Several authors have suggested that the difference score and Golden method
of quantifying interference are ineffective for various reasons (see Chafetz and Matthews,
2004; Lansberger, Kenemans, & van Engeland, 2007 also provide a review of this issue).
In turn, Lansberger et al. (2007) conducted a meta-analytic review of 19 studies
employing any Stroop color-word version in a comparison of DSM-IV-diagnosed ADHD
individuals and "normal" controls. These authors employed a ratio score of Color to
Color Word time per item, and found that interference control was consistently
compromised in ADHD individuals regardless of age. The mean effect size for tests
scored in time-per-item was g = 1.11. Using the items in 45" scoring, however, there was
great variability between studies. Unfortunately, the resulting effect size was not
presented. In addition to these results, the authors demonstrated that ADHD individuals
were consistently slower in base word reading (for 13 studies that provided these data,
t(12) = 5.19, p < .001). Thus, when scoring and analyzing data from the present study, it
may be appropriate to examine the base word reading T-score as well as the time per
item. The Stroop task was selected for inclusion in the present study for its utility in
ADHD evaluations, as well as to increase the ecological validity of the battery as that of a
diagnostic evaluation.
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Nelson-Denny Word Reading Test: Reading Speed Component
In this measure, a short non-fiction work is provided to participants, and they are
instructed to read it at their normal reading rate so that they may comprehend and
"absorb" the material, as "questions may be asked after." Individuals are instructed to
mark where they were after one minute of reading, by circling the corresponding number
at the right-hand side of the line they were on when told to stop reading in the present
study. No questions were asked; only the reading speed score was used.
The Reading Speed Component of the Nelson-Denny Reading Comprehension
Test (“N-D Comp”) was chosen for inclusion in the present study as some literature has
suggested that ADHD individuals perform significantly worse than their non-ADHD
peers (see Brock, 1996; Seidman, Biederman, Faraone, & Milberger, 1995). Moreover,
laypeople often associate slow reading with attentional problems. The research on this is
mixed, however, with greater evidence implicating reduced comprehension than
inattention per se (Brock & Knapp, 1996; Cordon, Kahl, & Wahl, 2006). This, however,
cannot be assessed in a timed test without evaluation of reading comprehension. In the
very least, this measure will serve to increase the ecological validity of the assessment
and to deter students from developing suspicion about the nature of the measures
administered, and may provide a gross indication of the difference between simulated and
diagnosed ADHD reading speed performance.
Wechsler Memory Scale—Third Edition, Word Lists Subtest
Word Lists (“WMS-III WL”) is an optional subtest from the WMS-III. It
involves memorization of 12 common, but neither semantically nor phonemically related
words (List A). This distinguishes it from other full reminding procedures, such as the
California Verbal Learning Test (CVLT; Delis, Kramer, Kaplan, & Ober, 1987), which
provide words that can be grouped into several semantic categories. In the WMS-III WL,
the examiner reads this list four times, each time after which the evaluee freely recalls all
words remembered in any order. Then, without instructing individuals to remember the
original list, a second 12-item list is provided for memorization and free recall one time
(List B). Finally, incidental memory of the first list is assessed with free-recall of those
items (Short-Delay Free Recall). Intrusions are recorded, and for this study, repetitions
were also recorded. A long-delay recall and recognition trial are also available, but these
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were not included in the present study.
Five raw scores are calculated from evaluee responses. The "First Recall Total
Score" is the sum of items recalled in List A Trial 1 and List B. The "Recall Total Score"
is the sum of all items recalled from List A and List B. The "Learning Slope" describes
rate of acquisition and is the mean number of items added per trials 2-4. "Contrast 1"
score describes the difference between the number of items recalled on Trial 1 List A and
List B. Lastly, the "Contrast 2" score describes the difference between number of items
recalled in Trials 4 and Trial 1. Each of these raw scores is converted to a T-score based
upon age group (18-19 or 20-24, 25-29, etc.).
The WMS-III standardization sample consisted of a demographically
representative group of 1,250 individuals aged 16-89. Reliability and validity data are
not presented for the WL itself as it is a supplemental subtest not scored on any scale, but
internal consistency is said to be greater than .70 for all subtests (see test manual). Testretest reliability for adults up to age 54 after a one-month period was found to be .61,
suggesting that performance on this subscale is susceptible to some temporal variability.
Notably, several feigning indices were developed or adapted for the WL scale in a
2005 dissertation (Larson, 2005). However, only one of these does not involve the longterm delayed recall portion of the WL. Responses from the immediate-recall trials listed
above can be used to calculate a Recall Consistency Index. This index was based upon
the Recall Consistency Index (Demakis, 1999) created for the CVLT. Larson's Recall
Consistency Index is a measure of consistency across only the learning trials of List A.
Each time a correct word is recalled in two successive trials, it is counted. (As such, each
word could potentially be counted three times). The score is the sum of these counts
divided by the total number of words recalled in Trials 1—3. Score interpretations are
found in Appendix I of the WMS-III manual.
Larson (2005) evaluated this index using a within-subjects simulation design that
included a clinical control group. Twenty community volunteers and twenty nonlitigating TBI patients with no current or past psychiatric diagnoses were asked to
complete measures to the best of their ability, and then, following a 10-minute break, to
simulate memory impairment. An effect size of d = 1.35 was found for the community
volunteer group, suggesting that it was a very good discriminator in a presumably
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unimpaired group; for the TBI group, the index was a mere d = .23. This suggests that
the index may only be useful for individuals without memory impairment. However,
classification accuracy was not calculated in that study, and these results do not preclude
the possibility that high true positive and true negative rates may be obtained using the
Inconsistency Index with non-impaired individuals, such as college students.
The WMS-III WL was included as a measure of immediate memory, and to
investigate the utility of the Inconsistency Index for feigned cognitive impairment.
Additionally, as with the other "true" neuropsychological measures, it served the purpose
of preventing participants from realizing that multiple feigning detection tools were being
administered. Other questions may be addressed through inclusion of this measure. For
example, at this time, very little research exists on list learning abilities of ADHDdiagnosed young adults. Intuitively, distractibility may be associated with poorer initial
list acquisition. A narrative review of neuropsychological testing results in ADHD
versus normal controls conducted by Woods, Lovejoy, and Ball (2002) demonstrated a
trend towards poorer performance on measures such as the California Verbal Learning
Test. However, examination of list learning in younger students has shown that they can
perform in the Average range (see Mahone, Koth, Cutting, Singer, and Denckla, 2001).
Additionally, no comparisons of feigning and ADHD college students exist for List
Learning Tasks.
It was hoped that performance patterns might be assessed in order to understand
both differences between honest and feigning ADHD "evaluees" and the performance of
individuals diagnosed with the disorder. Errors of commission and repetitions, which
may reflect impulsivity; or errors of omission, which may reflect distractibility (among
other neuropsychological functions) may be noted from the ADHD group. Mahone et al.
(2001) found a greater number of intrusion errors by ADHD-participants than by normal
controls. Of course, performance of children may not generalize to adults.
Neurocognitive Feigning Measures
36-Item Short Form, Hiscock-Hiscock Digit Memory Test Card Version
The Digit Memory Test (DMT) is considered by many to be the "gold standard"
of neurocognitive feigning tools (Vagnini et al., 2006; Vickery, Berry, Inman, Harris, &
Orey; 2001). This measure involves presenting a 5-digit stimulus, then a delay, and then a

32

two-alternative forced-choice recognition trial. The first "block" of items has a 2.5second delay; this is increased to 5 and then 10 seconds in attempt to make the test appear
as if it is becoming more difficult. Two score thresholds are useful in evaluating results
of the DMT: less than 90% correct, and statistically significantly below chance. The
former was derived from normative studies of non-compensation seeking individuals
with neurological damage instructed to perform to the best of their ability, and thus
represents the point at which probable feigning may be suspected. It was derived by
maximizing specificity. The latter is said to detect deliberate attempts to feign, derived
from the binomial theory.
Two meta-analytic reviews of primarily neurological patient groups have
demonstrated the procedure (Vickery et al., 2001) and a computerized variation (Sollman
& Berry, Under Review)—the Victoria Symptom Validity Test (Slick, 1999)—to have
the strongest sensitivity of all measures reviewed, as well as very high specificity. In
addition, very large effect sizes in the separation of purportedly honest and feigning
individuals has been demonstrated in the same reviews for those test variations (d = 1.95,
g = 2.71, respectively). The DMT was selected for this study due to these characteristics.
Letter Memory Test (Card Version)
The Letter Memory Test (LMT; Inman et al., 1996) was developed as an
alternative to the DMT under the assumption that increased public knowledge over time
may reduce utility of a measure. As with the DMT, the LMT was created to increase
evaluees' belief that it assesses memory and becomes more difficult over time. However,
it manipulates the number of characters (letters) presented, as well as the number of
alternative choices in the recall trial, rather than the delay length. For this measure, the
specificity-maximizing cutting score for probable feigning is 93%.
A meta-analytic review of known-groups and clinically-enhanced simulation
design studies is presented in Sollman & Berry (Under Review). This study provides
evidence that the LMT has a strong ability to separate groups of known or probable
feigning and honest individuals (g = 1.79). Although this effect size is significantly
lower than that of the DMT’s computerized counterpart, it still exceeds Cohen's
recommendations for a large effect size, when translated into Cohen's d. In the same
review, the LMT demonstrated mean sensitivity (76%) and specificity (98%) values that
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were statistically equivalent to those of the computerized DMT variant.
Test of Memory Malingering
The Test of Memory Malingering (TOMM; Tombaugh, 1996) is another twoalternative forced-choice measure, but it uses line-drawn "pictures of common objects"
rather than alpha-numeric characters as with the first two measures reviewed. Fifty such
pictures are presented in two learning trials, each of which is followed by a 50-item
forced-choice recognition trial. After a 20-minute delay, a final two-alternative
recognition trial is administered. The TOMM uses the below-chance criterion described
above as well as a standard cutoff of less than 90% correct on either Trial 2 or the
Retention Trial. In the Sollman and Berry meta-analytic review above, the TOMM was
demonstrated to have a high g (Trial 2 g = 1.31; Retention g = 1.47), which was not
statistically significantly different from that of the LMT. The Trial 2 effect size was
included in a cross-test comparison and was found to be equivalent to that of the LMT,
although significantly lower than the computerized DMT variant. As with the LMT,
near-perfect to perfect specificities were demonstrated (Trial 2 = 98%, Retention =
100%). Sensitivities were statistically equivalent to those of the LMT and computerized
DMT variant (Trial 2 = 65%, Retention = 68%), although this may be due to the small
number of contributing studies and the large variation between; a considerable difference
exists between the sensitivity values of the TOMM and VSVT (81%).
Green's Nonverbal-Medical Symptom Validity Test
This measure (NV-MSVT; Green, 2004) is the computerized "non-verbal"
component of Green's Medical Symptom Validity Test, which is a shortened adaptation
of Green's Word Memory Test. It is said to be usable in any sample regardless of
language spoken or reading level, though empirical data were not available. The NVMSVT was designed to detect when individuals are providing sub-optimal effort on a
perceived test of visual memory. Evaluees are presented with a list of 10 pictures, each
containing a pair of items, and are asked to name the components of each picture out
loud. The list is presented twice. Then they are shown two single-component pictures
side-by-side, asked to name each out loud, and then select the one that was in the tenpicture list (IR subscale). Feedback regarding accuracy is given by the computer. A tenminute delay then occurs, and the evaluee is not informed that long-term retention will be
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assessed later. During this delay, the evaluee is asked to memorize a set of 20 pictures
presented on a two-sided sheet, in one minute. The test manual instructs the examiner to
fill the remaining nine minutes with tasks not involving visual memory. Finally, evaluees
are presented with two pictures side-by-side and asked to select the one they saw on the
computer previously. This delayed recognition portion actually consists of three
intermixed subscales: the DR, where a new foil is paired with a learned target; the DRA,
where the two items presented include an easy-to-remember foil from IR with a
distinctively new foil; and the DRV, where an original target is presented with a similar,
slightly altered target. The examiner is asked to leave during this portion of the test, as
those evaluees intent on exaggerating impairment may be more likely to deliberately
select the incorrect response when left alone. Again, the computer provides feedback
regarding response accuracy. Next, individuals are provided with a single-component
picture from the original list of 10 two-component pictures. They are asked to verbally
indicate what the missing component is, and the examiner clicks either a green check
mark (to indicate correct response) or a red "X" (to indicate incorrect response) (PA
subscale). Lastly, the computer screen is turned away from the evaluee, who is asked to
freely recall the items presented in the original list of 10 pictures (FR subscale). The
evaluee may recall items singly or in pairs. At the close of the test, the evaluee is asked,
"Did you try your hardest on this test?" and their response is recorded on the computer.
In sum, this measure includes two two-alternative forced choice subtests, and two freerecall tests.
Feigning determination is made according to either of two algorithms. If the
mean of all subtest scores falls at or below 90%, or if the mean of DR, CNS, DRA, and
DRV falls below 88%, the individual is said to be feigning. The latter is said to be the
best combination for predicting TOMM or WMT failure according to ROC analysis. A
sensitivity of .70 and a specificity of .95 were found for predicting WMT failure at that
measure's cutting score of <88%. The cutting scores used for the NV-MSVT appear to
have been derived from the normal simulation comparison, based upon a graphic
illustration provided by the author, of these groups’ mean (non-overlapping) scores.
To date, there is no test manual and little data on the psychometrics of the NVMSVT. However, the author of this measure provided some data by personal
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communication. First, results of an unpublished non-clinically enhanced simulation
study illustrate that individuals asked to feign early dementia (N = 39) obtain
significantly lower scores on all subscales than normal controls (N = 36), with g effect
sizes all greater than 1.9 (range 1.9—3.5). Of note, simulators obtained a significantly
lower DRV subscale relative to the DRA and PA subscales than normal controls.
Examining these simulation data in comparison to an early dementia group (N = 8, only)
demonstrates g effect sizes ranging from 0.9 to 1.8. Here, simulators appeared to
overestimate the ability of mildly demented individuals on the PA subscale; the author
deems this the "Pinocchio Effect" due to the pointed appearance of the aggregated
simulators' profile. This has reportedly been replicated in an evaluation of NV-MSVT
evaluees failing the TOMM and WMT.
Despite current shortcomings and lack of validation, the NV-MSVT was selected
for inclusion in the present study for a number of reasons. First, it is the shortest
computerized measure known to the primary investigator, requiring only 6 minutes of
administration time (not including the 9 minute delay). It is believed that clinicians
would find computerized measures significantly more appealing than those involving
time-consuming administration. In addition, it may be that those individuals intent on
feigning may do so more readily when they do not have to provide their response to a
clinician. Thus, this test has potential to separate honest and feigning evaluees. This
measure was also very appealing because it seems to be particularly susceptible to errors
associated with poor self-monitoring (i.e., impulsivity or perseveration). Impulsive
responses may occur when an evaluee is in the habit of responding using quick mouse
clicks, and selects the wrong response by (a) clicking the mouse twice concurrently
before even "seeing" the next presentation (motor impulsivity), (b) selecting the option
on the same side as the previous correct response after noting the correct response, but
without moving the mouse over that response (general impulsivity), or (c) clicking the
option on the same side as the previous correct response after having multiple correct
selections on that side of the screen in a row, but before processing which is correct
(perseveration).
Psychiatric Feigning Measure
Because feigning strategies of students seeking a diagnosis of ADHD are not
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well-understood, it is unknown if false psychiatric symptoms are commonly presented.
Thus, the present study included one such measure.
The M-FAST
The M-Fast (Miller, 1999) is a 25-item structured interview that was developed to
aid clinicians in quickly identifying malingered mental illness. Administration takes
about five minutes, and scores are provided on seven scales: Unusual Hallucinations,
Reported Versus Observed Symptoms (assessing symptom reports that do not correspond
with actual behavior), Extreme Symptomatology (assessing endorsement of a greater
number or severity of symptoms than actual psychiatric patients), Rare Combinations
(assessing symptoms that rarely or never coexist), Negative Image (assessing selfportrayal in an unusually negative light), Unusual Symptom Course (assessing responses
not reflecting the actual gradual onset of true mental illness), and Suggestibility.
The M-FAST was chosen for inclusion over other psychiatric feigning measures
because some of the above scales appeared to correspond to ADHD symptoms.
Additionally, it seemed that various items on this measure could be applicable to ADHD,
or could be construed as assessing its symptomatology (e.g., "I often have a hard time
sitting still;" "Whenever I sit in a chair I have to breathe deep breaths in order not to get
sick;" "Sometimes I hear a radio playing when there is not one on near me"—the latter
corresponding to media reports that some peoples' mental ADHD experience is like a TV
changing channels). Unfortunately, there are no known studies of the M-FAST's utility
in ADHD evaluations; instead, research to date has been limited to general psychiatric
and forensic samples. This is summarized in Table 1-3 below.
M-FAST development and validation were completed using 546 forensic
psychiatric inpatients and undergraduates. It was found to have good convergence with
the gold standards of the time: the MMPI-2 fake bad indices and the Structured Interview
of Reported Symptoms (SIRS; Rogers, Gillis, Dickens, & Bagby, 1991). Using the
MMPI-2 defensiveness and "good impression" indicators, discriminant validity was also
demonstrated. Lastly, the M-FAST was found to have strong reliability (alpha = .94,
test-retest reliability = .91, p < .001). A brief review of the available known groups and
clinically enhanced simulation studies is provided in Table 2-1 below. All studies
utilized forensic or psychiatric patients, which limits generalizability to the present
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Table 2-1
Summary of Known-Groups and Clinically Enhanced M-FAST Evaluations

Reference

Des

Group

N

Miller, 1999 a

KG

MAL
HON

14
36

FP
FP

MAL
HON

21
29

FP
FP

MAL
HON

-

FP
FP

MAL
HON
MAL
HON

8
41
43
96

FP
FP
FP
FP

MAL
HON

5
39

IP
IP

MAL
HON
MAL
HON
MAL
HON
MAL
HON

48
48
41
20
51
25
50
47

Students
Scz
Students
BP
Students
MDD
Students
PTSD

Guy & Miller,
2004 a

KG b

Miller, 2004 a

KG b

Jackson,
Rogers, &
Sewell, 2005

KG b

Veazey, 2005

KG d

Guy, Kwartner
& Miller, 2006

ES

ES

e

ES e
ES e
ES e

Sample

MALHON g
-

1.9
-

cut
score
>9
>6
>6

2.8
>6

Sn
.86

.83
.86
.83
.93
.83
.76 c
. 90 c

1.9
-

>6

2.7

>6

1.4

>6

1.7
1.2

>6
>6

Sp

.80
.85
.88
.82
.84
.79
.62
.79
.63
.85

Alwes, Clark,
KG
MAL
75
>6
CF, P
.83
1.0
Berry, &
HON
178
CF, P
.91
Granacher,
KG
MAL
23
>6
CF, N
.43
3.0
2007
HON
172
CF, N
.88
Note. g = Hedges’ g effect size. Effects calculated using means and standard deviations, except for
Guy & Miller (2004), using t-score results. No study reported feigning incentive. Only Jackson,
Rogers & Sewell (2005) provided a warning to feigners and a compliance check. - = missing or
unable to determine; BP = bipolar disorder patients, CF = civil forensic (outpatient), Des = design,
ES = clinically-enhanced simulation design; FP = forensic (imprisoned) psychiatric, IP = inpatient
psychiatric, KG = known-groups design; N = neurological claim, n/a = not applicable, P =
psychiatric claim, Scz = schizophrenic patients, Sn = sensitivity, Sp = specificity.
a
It is unclear if there was participant overlap in these three studies, which used the same classification criteria but reported a slightly different demographic makeup. Most likely, Miller (2004)
provides data from Miller (1999). b SIRS used for classification. c Values derived from combination of the two studies. d PAI Malingering Index used for classification. e Each clinical group
had a corresponding feigning group, so no two effect sizes or test parameters were drawn from the
same individual.
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student and ADHD sample. However, a very large mean g was demonstrated after
correcting for sample size (g = 1.7). Using a cutting score of > 6, sensitivity across
studies was moderately high at .77, and specificity was moderate at .84.
Scoring and Data Entry
All measures were scored according to standardized instructions. The Stroop was
additionally scored with the literature-recommended time per item score. Scoring and
data entry were independently cross-checked for accuracy by two individuals at the conclusion of data collection. Review of twenty percent of files resulted in an inter-rater
reliability greater than 99% (due to seven errors), so no additional files were checked.
Manipulation Checks
Two manipulation checks were employed. In the first, individuals’ post-test
questionnaires were examined to determine if they accurately summarized instructions
(e.g., “to fake ADHD” or “to take these tests honestly and with my best effort”) and
reported providing adequate effort according to a Likert rating of at least three out of five
points. The second manipulation check involved assessing group accuracy. HON and
ADHD results were examined to determine if they diverged; that is, to support the
clinical nature of that experimental group. These results are provided in the next section.
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Chapter Three: Results
Sample Description
A total of eighty undergraduates from the University of Kentucky participated in
the study. Of these, seven were excluded for various reasons: two Honest-role subjects
were non-native English speakers and struggled with the protocol, one Feigning-role
participant did not pass the post-test by rating effort at least three out of five, and four
ADHD participants did not provide evidence for a valid diagnosis of the disorder (by
clinically elevating at least one ADHD-diagnostic measure). No HON student elevated
any measure or subscale believed to be “diagnostic” of inattention. Thirty FGN, twentynine ADHD, and fourteen HON participants remained. (The HON control group served
simply as a manipulation check, described later, so few participants were needed).
Demographics are provided by group in Table 3-1. As can be seen, the groups were
equivalent in terms of gender, age, number of months of college, ethnicity, handedness,
and WTAR-estimated FSIQ. Overall, this university sample represents a younger undergraduate group with an Average-range mean WTAR predicted FSIQ of 105.4 (SD = 8.1).
Because not all ADHD students were completely sure of their current diagnostic
subtype, this was estimated by scoring the ARS and CAARS:S—L symptom checklists
according to manualized instructions. Based on these results, the ADHD group is best
described as predominantly Combined subtype (about 75%), with a substantial group
being Inattentive (>20%), and a minority being Hyperactive-Impulsive (<5%), according
to symptom reports. There were two modal ranges of age at diagnosis: 8-12 and 16-18,
representing 31.0% and 34.4% of the sample, respectively, though the overall range of
age at diagnosis spanned from four to twenty-one. The majority of ADHD students
(41%) were diagnosed using a brief neuropsychological assessment (including
psychological, IQ, and learning disability testing), while 31% received a full neuropsychological evaluation and 21% received a comprehensive psychological evaluation
including corroborative interviews of parents and teachers. A minority were diagnosed
using methods not meeting the above classification (e.g., psychological evaluation and IQ
testing only). With regard to treatment, almost one-fifth of the students (17.9%) reported
using behavioral techniques rather than medication due to side effects. For those who
provided a description of their medication (N = 21), the majority received a form of
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Table 3-1
Demographic Characteristics of Participants Included in Final Analyses
Group
Variable

HON
N = 14

FGN
N = 30

ADHD
N = 29

F or χ2

p

Male

%

50.0

46.7

55.2

0.430

.807

Age

M
SD

18.9
1.03

19.1
1.28

19.4
1.21

1.209

.304

Months of College

M
SD

12.3
10.25

13.2
10.56

16.3
12.89

0.787

.459
.197
-

Race/Ethnicity Overall
Caucasian
%

100

83.3

86.2

8.599
-

Black

%

0

6.7

6.9

-

-

Asian

%

0

10.0

0

-

-

Multiracial

%

0

0

6.9

-

-

Right-handed

%

85.7

90.0

93.1

0.605

.739

WTAR est. FSIQ

M
SD

105.8
8.15

105.8
8.15

105.6
8.54

0.036

.965

Note. HON = Honest, FGN = Feigning, WTAR est. FSIQ = Wechsler Test of Adult Reading
estimated Wechsler Adult Intelligence Scale—III Full Scale IQ.
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Adderall (57.8%), and about half (48.3%) were treated with an extended release
medication. The accuracy of these reports was not verified by checking medical records.
Comparison of results from the HON and ADHD groups, as illustrated throughout
the Results section below, indicated that ADHD participants’ results diverged from those
of the normal HON group. This reflects global symptom report and performance
differences between the presumably clinical participants and the undiagnosed,
presumably normal students, and loosely supports both the validity of the ADHD group
makeup and the validity of measures used to distinguish these groups.
Results from Core Battery
Data Presentation and Analytic Strategy
In order to facilitate clarity in data presentation and analyses, the following
structure will be broadly followed: First, for each instrument, between group analyses of
major indices will be undertaken using ANOVA or Mann-Whitney U as appropriate.
Next, in order to evaluate whether feigning actually occurred, results from the HON and
FGN groups will be contrasted. Following this, to assess feigning success, the ADHD
and FGN groups will be compared. Then, in order to evaluate individual classification
rates, slightly different analyses will be undertaken for the ADHD-diagnostic vs.
malingering measures. For the ADHD-diagnostic indicators, Sensitivity and Specificity
rates for the contrasts of HON vs. ADHD will index diagnostic properties, whereas the
same parameters for the ADHD vs. FGN comparison will illustrate potential error rates in
settings that have a mixture of feigning normals and genuine ADHD evaluees. For the
malingering indicators, the diagnostic parameters will be presented only for the ADHD
vs. FGN contrast, as these are the operating characteristics of most interest in the present
study. Finally, in a later section, logistic regression will be employed to determine the
optimal combination of indicators for identification of ADHD vs FGN status.
Attention-Related Measures
CAARS—S:L : Results are provided in Table 3-2. One-way ANOVAs indicated
a significant main effect for group on every measure from this instrument. Follow-up
pairwise comparisons using Tukey's HSD at p < .05 identified a consistent pattern across
all scales, such that the FGN group was statistically significantly higher than the HON
group and the FGN group was comparable to the ADHD group. The former results
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Table 3-2
CAARS—S:L Scale T-scores (M [SD])
FGN-ADD

43

Variable
Scale 1

49.9 (7.11) a

71.0 (10.43) b

66.9 (12.23) b

19.140

.000

354.5

.222

0.36

Scale 2

44.9 (8.73) a

66.7

(8.80) b

63.9 (9.38) b

29.853

.000

360.0

.255

0.31

Scale 3

42.7 (6.84) a

64.1 (12.19) b

59.7 (12.34) b

17.042

.000

358.5

.246

0.36

Scale 4

43.7 (7.25) a

55.2 (10.20) b

53.3 (10.53) b

6.761

.002

396.0

.554

0.18

Scale 5

51.9 (10.06) a

79.4

(9.43) b

79.6 (11.20) b

40.705

.000

432.5

.970

-0.02

Scale 6

42.1 (8.43) a

72.0 (11.00) b

69.9 (12.48) b

38.014

.000

381.5

.417

0.18

Scale 7

47.1 (9.65) a

80.2

(9.49) b

78.5 (10.11) b

61.818

.000

395.0

.543

0.18

Scale 8*

45.4 (9.47) a

67.0 (11.54) b

63.6 (9.90) b

20.952

.000

356.0

.320

0.31

Overall Mean

46.0 (0.45) a

69.5

(8.84) b

66.9 (8.27) b

40.671

.000

386.0

.453

0.30

0.1 (0.27) a

5.1

(2.33) b

4.6 (2.23) b

31.088

.000

363.5

.278

0.21

Number of Scales > 65T

FGN
N = 30

Overall

HON
N = 14

ADHD
N = 29

F

p

U

p

g

Note. Within each row, columns with different letters are statistically different (p < .05) from one another according to Tukey post-hoc testing.
FGN-ADHD = comparisons involving those groups only; g = Hedges’ g effect size; Overall = comparisons involving all three groups.
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suggests that analog feigners endorsed symptoms at a significantly higher rate than
control participants; the mean elevations here are mostly in the clinically significant
range according the manual for the test (i.e., > 65T). The non-significantly different
scores for the FGN and ADHD contrasts suggest that feigners approximated the symptom
reports of students diagnosed with ADHD. This lack of difference is also illustrated by
the rank distribution of scores for the FGN and ADHD groups according to the MannWhitney U Test, which reflects a comparable number and degree of elevated scores for
those groups. Further, the median FGN-ADHD contrast g was .18, which barely approximates a small effect size. These results suggest that normal students could easily feign
ADHD symptoms on the CAARS-S:L to a comparable extent to those with the diagnosis.
Table 3-3 presents Sensitivity and Specificity values of the CAARS—S:L for
distinguishing HON and ADHD as well as FGN vs. ADHD contrasts. Results indicate
perfect Specificity for the HON vs. ADHD contrast, but only modest Sensitivity (median
= .586). Findings were considerably worse for the FGN vs. ADHD contrast. Here
Specificity calculated using FGN results was very poor (median = .650), although
Sensitivity remained moderate (median = .350) as it was calculated using the same
ADHD group as in the previous contrast. Overall, these results suggest that the CAARSS:L is modestly effective at discriminating honestly responding students with ADHD
versus honestly responding normals. However, the instrument is essentially unable to
distinguish normals feigning ADHD from those with the condition who responded
honestly. In this regard, it should be noted that the CAARS—S:L has not been
previously validated for discrimination of feigned vs genuine ADHD.
CAARS—S:L additional considerations: In clinical evaluations of the
CAARS—S:L, the authors suggest that two factors be considered when determining if a
profile is clinical or not: performance on Scale 8, and the number of scales elevated. As
with the other scales, a T-score greater than 65 is considered clinically noteworthy on
Scale 8. In the present sample, the ADHD mean score’s 95% confidence interval did not
fall entirely within the range of clinical elevation, though the average and score
distribution were not statistically different from that of the FGN group, which was
clinically elevated. As such, Scale 8 may not be the most robust index of clinical status
for undergraduates. A sensitivity value of .448 furthers this contention.
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Table 3-3
Clinical Elevation on CAARS—S:L Scales (> 65T), By Group
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Variable

HON
N = 14

FGN
N = 30

ADHD
N = 29

Sn to
ADHD

Sp for
HON

Sp for
FGN

Scale 1

0

22

19

.655

1.000

.267

Scale 2

0

16

15

.517

1.000

.467

Scale 3

0

14

11

.379

1.000

.533

Scale 4

0

6

4

.138

1.000

.800

Scale 5

0

28

27

.931

1.000

.067

Scale 6

0

22

20

.690

1.000

.267

Scale 7

0

28

25

.862

1.000

.067

Scale 8*

0

17

13

.448

1.000

.433

0—1 Scales Elevated

0

1

3

NR

1.000

.967

Up to 3 Scales Elevated

0

11

7

NR

1.000

.633

6—8 Scales Elevated

0

15

12

.414

1.000

.533

4—8 Scales Elevated

0

19

22

.759

1.000

367

Ruling Out ADHD:

Ruling In ADHD:

Note. The condition of interest (for sensitivity) is ADHD. HON-ADHD = analyses involving those conditions; NR = not relevant; Sp =
Specificity; Sn = Sensitivity; *The test manual recommends that Scale 8, and the number of scales with clinical elevations (>65T), be examined
when making a diagnostic decision.
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Turing to the number of scales elevated above 65T, the test manual does not
provide a guideline regarding the number of scales that should be elevated for a clinical
determination. In this study, the FGN and ADHD groups produced equivalent numbers
(ADHD M = 4.6 [SD = 2.23], FGN M = 5.1 [SD = 2.31]) and distributions (U = 363.5, p
= .278) of elevated scales (see Table 3-2). This suggests that it does not discriminate
feigned from diagnosed ADHD. However, because a clinically significant profile was
required on at least one of the ADHD-diagnostic measures for ADHD participants to
remain included in the study (as stated earlier), this may be biased. As depicted in Table
3-3, though more than four elevations pointed to attention dysfunction in this sample
(Sensitivity = .759, Specificity for HON = 1.000), it did not distinguish feigned from
actual attention problems (Specificity = .367).
ARS: This measure is scored differently from the Conners’ scales, as raw scores
are interpreted in light of gender-based cut scores. As such, it was necessary to analyze
data for males and females separately. Univariate ANOVA was used for this task to
examine for main effects of gender and role, as well as an interaction of the two. ARS
endorsements for the Childhood and Current Symptoms scales are provided in Table 3-4,
collapsed across gender for simplicity.
Overall, results closely matched those of the CAARS-S:L. There was a significant
main effect for group on every index, which according to follow-up contrasts using
Tukey HSD at p < .05 indicates that the FGN group endorsed significantly more items in
a “clinical” manner (by rating them 2 or 3) than the HON group. Also, the FGN group
endorsements were similar to the ADHD group’s for every subscale. Analog feigners’
endorsements were generally consistent with clinical elevation, for both males and
females. Collapsed by gender, effect sizes for the Inattentive and Hyperactive subscales
were small for all scales (median g = .31), but were larger on those subscales were gender
effects were noted due to the tendency of female feigners to rate more symptoms 2 or 3.
These included both Childhood subscales, as indicated with footnotes in Table 3-4 below.
Table 3-5 presents sensitivity and specificity values of the ARS for distinguishing
HON and ADHD as well as FGN vs. ADHD contrasts. Just as with the CAARS:S—L,
results indicate perfect specificity for the HON condition when contrasted with ADHD.
Sensitivity to ADHD was somewhat higher (mean = .785) for this measure. Specificity
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Table 3-4
Barkley-Murphy ARS Test Results Collapsed Across Gender: Number of Clinically Relevant
Endorsements (M [SD])
HON
N = 14

Variable (Cut Score)

FGN
N = 30

ADHD
N = 29

Overall
p

FGNADHD
g

Current Scale
Inattentive (> 4)

.5 (1.16) a

6.4 (2.66) b

5.5 (2.60) b

.000

.31

Hyperactive (> 5)

.3 (0.61) a

5.7 (2.48) b

5.3 (2.25) b

.000

.18 2

Total (NA)

.8 (1.48) a

12.1 (4.88) b

10.8 (4.19) b

.000

.15

Inattentive (M>7, F>6)

1.2 (1.53) a

7.3 (2.26) b

7.0 (2.06) b

.000

.49 3

Hyperactive (M>7, F>6)

1.0 (1.71) a

7.4 (2.14) b

6.6 (2.18) b

.000

.44 4

Total (NA)

2.2 (3.02) a

14.7 (4.10) b

13.6 (3.60) b

.000

.36 5

7.0 (2.25)

7.5 (4.03)

.768

-.20 6

Childhood Scale

Est. Age Onset (NA)

-

Note. Data were analyzed using Univariate ANOVA due to lack of gender norms. Means and
effect sizes collapsed by gender for this table, though analyses produced separate results. Means
represent the number of items endorsed two or three on a Likert spanning from zero to three.
Statistics provided for FGN-ADD contrast. Within each row, columns with different subscripts
are significantly different, p < .05, according to post hoc testing. Gend = gender; Grp = group;
Intxn = interaction; mean g = average Hedge’s g effect size indicator (combined for males and
females); M = male; F = female.
1

Gender effect reflects that males’ scores were lower than females’ scores.

Female g = .39.

3

Male g = -.31, Female g = .66.

4

Female g = .87. 6 Male g = -.46, Female g = .07.

47

2

Male g = -.04,

Male g = .00, Female g = .87.

5

Male g = -.16,

Table 3-5
Frequency of Clinical Classification on ARS Indices, Using Age and Gender-Based Norms (Murphy & Barkley, 1996)
HON
(N = 14)

FGN
(N = 30)

ADHD
(N = 29)

Sn to
ADHD

Sp for
HON

Sp for
FGN

Inattentive Endorsements

0

24

24

.828

1.000

.200

Hyperactive Endorsements

0

18

19

.655

1.000

.400

(0)

(24)

(25)

.862

1.000

.200

Inattentive

0

6

6

-

-

-

Hyperactive

0

0

1

-

-

-

Combined

0

18

18

-

-

-

Inattentive Endorsements

0

25

22

.759

1.000

.167

Hyperactive Endorsements

0

20

26

.897

1.000

.333

(0)

(28)

(26)

.897

1.000

.067

Inattentive

0

2

6

-

-

-

Hyperactive

0

3

4

-

-

-

Combined

0

23

16

-

-

-

Current Symptoms Scale

Current Symptom Clinical Classification *
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Childhood Symptoms Scale

Childhood Symptom Clinical Classification *

Note. Endorsements refer to items rated 2 or 3 on the 0—4 Likert. *Values in parentheses represent total of individuals meeting classification
criteria for Inattentive, Hyperactive, or Combined subtype.
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in the FGN-ADHD contrast was poor for this measure (mean = .275), indicating that it
essentially does not discriminate between normals feigning ADHD and ADHD patients
responding honestly. However, as with the CAARS—S:L , the ARS has not been
previously validated for discrimination of feigned vs genuine ADHD.
Additional ARS Considerations: On the ARS, individuals are additionally
asked to estimate the age of onset of the rated problems. Participants in the FGN and
ADHD groups reported comparable symptom onset ages (overall M = 7.0 [SD = 2.25]),
with no main effects or interactions for gender and role. It should be noted that coaching
material provided the DSM-IV criterion that symptoms must be present before age seven.
ARS-identified subtypes are explored later under the heading of Feigning Strategies.
Continuous Performance Test: C-CPT results are provided in Table 3-6, and
diverge somewhat from the results of the Symptom Report measures described above.
Although there were significant main effects of group for several indices, neither the
number of perseverations, Hit Rate, Beta, nor any variable examining changes across
response block or stimulus item showed an effect. (Note that Hit Rate and Beta were
examined as two-tailed indices due to clinical scores being <35T and >65T). This calls
into question the validity of these variables for distinguishing clinical versus normal
individuals, so they will not be discussed further. Of further concern, of those seven
variables with a significant main effect of group, follow-up pairwise contrasts revealed
no significant difference between HON and ADHD for five; and, for three (Omissions,
Hit Rate SE, Variability), the FGN group was significantly higher than the ADHD group.
In fact, the ADHD group did not have a mean above the clinical cut score (65T) on any
index.
Table 3-7 presents sensitivity and specificity values of the CAARS—S:L for
distinguishing HON and ADHD as well as FGN vs. ADHD contrasts. For the selected
indices that showed a main effect of group in the previous analyses, these results indicate
near-perfect specificity for HON vs. ADHD (median Sp = .714), and low to moderate
Specificity for FGN vs. ADHD (median = .621). Not surprisingly, though, Sensitivity to
ADHD was very poor (median = .241). Overall, these results suggest that the C-CPT is
ineffective in identifying undergraduates with ADHD, relatively good at ruling out
symptoms in normals presumed to be performing to the best of their ability, but poor at
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Table 3-6
Conners’ CPT T-scores for Indices Where T > 65 is Indicative of Clinical Profile
Overall

FGN-ADD

HON
N = 14

FGN
N = 30

ADHD
N = 29

F

p

U

p

g

Omissions

46.4 (4.24) a

85.4 (46.01) b

61.2 (24.15) a

7.596

.001

301.0

.042

0.65

Commissions

48.2 (14.67) a

63.5 (10.02) b

59.5 (9.93) b

9.319

.000

351.0

.203

0.40

Hit Rate SE

50.5 (9.56) a

70.4 (17.48) b

60.0 (15.81) a

8.419

.000

283.5

.022

0.62

Variability

49.8 (8.62) a

67.5 (13.09) b

58.2 (13.77) a

10.099

.000

257.0

.007

0.70

Detectibility

50.6 (8.63) a

59.4 (5.43) b

57.4 (6.90) b

8.280

.000

351.0

.203

0.31

Perseverations

48.3 (5.51)

81.7 (91.50)

61.3 (26.03)

1.641

.201

347.5

.181

0.30

Hit Rate Block Change

48.3 (7.56)

52.2 (12.95)

47.4 (12.15)

1.332

.270

367.5

.306

0.38

Hit Rate SE Block Change

55.8 (7.94)

53.5 (13.09)

52.2 (10.17)

.480

.621

420.5

.826

0.11

Hit Rate ISI change

58.8 (12.40)

67.7 (19.89)

61.6 (17.32)

1.603

.209

355.0

.225

0.33

Hit Rate ISI SE change

53.3 (9.40)

62.6 (15.44)

58.2 (11.97)

2.488

.090

375.0

.363

0.31

Variable
Index T-scores
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Number Scales >65T
“% Clinical Agreement”

1.1 (1.56) a

3.9 (2.98) b

2.3 (2.44)

6.362

.003

296.0

.033

0.58

42.4 (17.76) a

71.4 (26.40) b

60.3 (24.04)

7.005

.002

327.5

.090

0.44

Note. Within each row, columns with different letters are statistically different (p < .05) from one another according to Tukey post-hoc testing.
“Hit Rate” and “Beta” not provided because distributions are binomial due to clinical scores being <35T and >65T; using Univariate ANOVA
no main effect of group observed. FGN-ADHD = comparing those groups only; g = Hedges’ g effect size; Overall = comparing all three groups.
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Table 3-7
Frequency of Clinical Elevation on C-CPT subscales, for Those with Group Differences
HON
(N = 14)

FGN
(N = 30)

ADHD
(N = 29)

Sn to
ADHD

Sp for
HON

Sp for
FGN

0

14

7

.241

1.000

.533

Omissions

0

14

7

.241

1.000

.533

Commissions

2

12

9

.310

. 857

.621

Hit Rate *

4

9

7

.241

.714

.724

Hit Rate SE

0

18

7

.241

1.000

.400

Variability

1

16

7

.241

.929

.483

Detectibility

1

4

5

.172

.929

.897

Beta *

0

0

0

.000

1.000

1.000

Mean Index Score >65T
Index

Note. *Clinical elevation at >65T, except Beta and Hit Rate, where clinical at <35T and
>65T. Subscales indicative of inattention include Omissions, Hit Rate Block Change, and Hit
Standard Error Block Change. Subscales indicative of hyperactivity/impulsivity include
Commissions, Perseverations, and Hit Rate (using values <35T for the latter). NA = not

applicable because bi-directional test not possible; ns = not significant; Sn = sensitivity to
ADHD, Sp = specificity.
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avoiding false positive diagnoses for FGN. Overall, individuals in this sample with
clinical elevations are likely to be FGN-role.
Additional C-CPT Considerations: The variable “Percent Clinical Agreement”
(presented in Table 3-6) indicates the percent correspondence between an individual’s
profile and the standardization sample’s mean clinical profile. It is the first information
provided in a C-CPT report, suggesting it is believed to be a good overall indicator of
attention dysfunction status. On this variable, the FGN group obtained a mean clinical
profile agreement of 71.4% (SD = 26.40). According to post-hoc analyses, this value was
significantly different from that of the HON group, which obtained a high mean clinical
profile agreement of 42.4% (SD = 17.76). The mean ADHD group Percent Clinical
Agreement was not different from either FGN or HON, and fell at chance (50%).
Summary of ADHD-Diagnostic Results: In summary, both symptom checklists
administered (the CAARS:S—L and the ARS) were highly unlikely to classify normals
responding honestly as ADHD and were relatively sensitive to ADHD, but were very
easily faked. At published cutting scores, the C-CPT indices were insensitive to the
attention dysfunction of the ADHD group.
Results of Standard Neuropsychological Testing
Three neuropsychological tests were administered: the Nelson-Denny
Comprehension subtest Reading Speed component (N-D Comp), the Stroop Color-Word
Test (Charles Golden Version, 2002), and the WMS- III Word Lists Immediate subscales
(WMS-III WL). Because no cut scores are available for these measures, sensitivity and
specificity are not explored.
N-D Comp Results: Students were administered the N-D Comp with instructions
to read at their usual rate, “for comprehension.” There was no between-group difference
in either reading rate (Overall, F(2) = 1.360, p = .393) or in the distribution of reading
times, after removing three outliers that were each more than three standard deviations
above the mean. Thus, all three groups read comparable numbers of words. On average,
the HON group read 188 words per minute (SD = 40.8), feigners read 182 (SD = 42.1),
and ADHD read 167 (SD = 46.1). Thus, this component of the test has little diagnostic
utility in ADHD undergraduates.
Stroop Task Results: For each Stroop subscale (Word, Color, and Color-Word),
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three types of scores were calculated: T-scores according to instructions within the
manual, words read per second, and errors per subscale. T-scores account for errors via
increased reading time. These results are presented in Table 3-8 and discussed separately.
Regarding the Subscale T-scores, lower scores are more indicative of pathology.
Here, significant main effects of group are seen for all indices except the controversial
Interference score discussed earlier. For those with group differences, follow-up pairwise
comparisons indicate that the FGN group read significantly slower than the HON group
for all. The FGN mean was significantly lower than ADHD group mean only on the
Word subtest, where significantly more feigners scored in the impaired direction. This is
supported by a large FGN-ADHD effect size (g = -1.06). The HON and ADHD groups
had equivalent mean T-scores on all subtests, indicating that theses indices were
insensitive to difficulties associated with ADHD.
Examining the mean number of words read per second, previously suggested to
be a more accurate indication of reading speed, the resulting patterns and effects were
identical to the above. This suggests that the scoring methods are comparable in these
samples. In combination with results from the Nelson-Denny Reading Test, it
additionally suggests that ADHD undergraduates do not read significantly slower than
presumed normal students.
Turning to the raw number of errors, main effects of group were observed for the
Word and Color subtests. Follow-up tests reveal different patterns of results, however.
On the Word subscale, feigners provided more errors than presumed normals. However,
there were statistically equivalent numbers and distributions of errors for the FGN and
ADHD groups. This is supported by the only moderate effect size, .48. Of note, the
ADHD group did not achieve significantly more errors than the HON group. On the
Color subscale, the FGN group again produced more errors than the HON group; but the
FGN group also more errors than the ADHD group, resulting in a slightly larger effect
size for this contrast (g = .63). Again, the ADHD and HON groups were statistically
equivalent.
WMS-III WL Results: The WMS-III WL was scored according to manualized
instructions, to produce various index Scaled Scores (as well as feigning indices
described later). These results are presented in Table 3-9, and show a main effect for
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Table 3-8
Stroop Test Results (Mean [SD])

Variable

HON
N = 14

FGN
N = 30

ADHD
N = 29

Overall
F

FGN-ADD
p

U

p

g

12.752

.000

198.5

.000

-1.06

Subscale T-score

54

Word

48.3 (13.96) a

30.9 (12.18) b

43.0 (10.65) a

Color

47.1 (10.23) a

37.5 (11.51) b

43.2 (9.92)

4.419

.016

309.0

.056

-0.53

Color-Word

52.8

(9.52) a

43.2 (12.16) b

47.7 (8.49)

4.427

.018

313.0

.064

-0.43

Interference

55.4

(5.88)

54.0 (8.67)

53.2 (7.14)

.391

.678

412.0

.727

0.10

12.133

.000

194.0

.000

-1.05

Mean Words / Second
Word

2.3 (.46) a

1.7 (.40) b

2.1 (.36) a

Color

1.7 (.28) a

1.4 (.31) b

1.6 (.26)

4.388

.016

308.5

.055

-0.70

Color-Word

1.1 (.23) a

0.9 (.27) b

1.0 (.19)

4.348

.017

307.0

.052

-0.43

Word Errors

0.0 (.00) a

1.0 (1.89) b

0.3 (.55)

3.586

.033

378.0

.303

0.48

Color Errors

0.1 (.27) a

1.0 (1.54) b

0.2 (.51) a

5.005

.009

338.5

.058

0.63

Color-Word Errors

0.4 (.65)

1.0 (1.40)

0.6 (.91)

1.065

.350

417.0

.755

0.26

Raw Number Errors

Note. Within each row, columns with different letters are statistically different (p < .05) from one another according to Tukey post-hoc testing.
FGN-ADD = statistics involving only those participant groups; Overall = statistics involving all three participant groups.
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Table 3-9
WSM-III Word Lists Results
HON

FGN

ADHD

N = 14

N = 30

N = 29

1st Recall

11.1 (3.08)

9.4 (2.16)

9.4 (3.03)

Recall Total

11.4 (2.47) a

7.8 (2.86) b

Learning Slope

9.5 (2.65)

Contrast 1
Contrast 2

Variable
Subscale Scaled Score:

Overall
F

FGN-ADD
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p

U

p

g

2.130

.126

416.5

.775

0.00

9.0 (2.73) b

8.073

.001

320.0

.079

-0.43

8.2 (2.16) a

10.1 (3.74) b

2.896

.062

300.0

.038

-0.60

9.6 (2.13)

9.7 (2.13)

10.4 (2.81)

.680

.510

351.5

.199

-0.29

10.1 (3.23) a

7.7 (3.49) b

10.5 (2.36) a

6.738

.002

232.0

.002

-0.92

N = 14

N = 30

N = 29

0.1 (.27)

1.0 (1.81)

1.0 (1.20)

2.426

.096

388.5

.439

-0.02

N=5

N = 11

N = 24

2.0 (2.55)

1.2 (1.40)

2.9 (2.89)

1.719

.193

230.5

.000

0.67

Pilot Variables:
Number of Intrusions*

Number of Repetitions*

Note. Within each row, columns with different letters are statistically different (p < .05) from one another according to Tukey post-hoc testing.
FGN-ADD = statistics involving only those participant groups; Overall = statistics involving all three participant groups.
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group on only two of the five variables: Recall Total (sum of words recalled in Trials 1
through 4) and Contrast 2 (difference in number of words recalled in Trial 4 and the Short
Delay). For Recall Total, pairwise post-hoc tests indicate that the FGN group recalled
significantly fewer words than the HON group and an equivalent number to the ADHD
group. This is supported by a relatively small effect size in the FGN-ADHD contrast (g =
-.43) and a lack of difference in the distribution of FGN and ADHD scores. The ADHD
group was equivalent in performance to the HON group, suggesting this is not an area of
difficulty for this clinical sample. For the Contrast 2 variable, feigners achieved significantly lower scores due to recalling fewer words at the Delay than both HON and
ADHD groups, whose recalls were statistically equivalent (Tukey HSD p = .002; Mann
Whitney p = .002). These results suggest that Contrast 2 is likely the most effective at
discriminating feigned from honest performance, according to the large FGN-ADHD g of
-.92. However, the WMS-III WL subtests are broadly ineffective at separating
performance of ADHD from normal students responding honestly.
For this study, the total number of intrusions provided across all learning and
recall trials was recorded to determine if this variable discriminate feigned or genuine
ADHD from presumed normal honest performance. There were no between-group
differences, precluding this notion. There was likewise no effect in the FGN-ADHD
contrast (g = -.02). In addition to the number of intrusions, the number of repetitions was
recorded for a minority of participants. Power to detect a difference is minimal, and no
main effect of group was noted. However, score distributions indicate that significantly
more ADHD than FGN participants provided repetitions (U = 230.5, p = .000), and a
moderately high effect size of -.67 was observed for this contrast. Thus, examining
repetitions may prove helpful in identifying genuine ADHD.
Neuropsychological Test Result Summary: Overall, ADHD participants were not
likely to obtain reduced neuropsychological test scores relative to presumed normals.
FGN-group performance on neuropsychological testing resembles that of the research on
feigned head injury (described earlier) in that malingerers’ performance was generally
suppressed. However, the size of FGN-ADHD group separation in this study, as
evidenced by effect sizes, was less than is commonly seen in known-groups assessment
of neurological insult groups. Though the nature of this study’s design does not make it
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directly comparable to the real-world counterpart (known-groups), the observation
suggests that undergraduates were successful at making themselves not look too
impaired, an issue for which they were coached. This further hints that using neuropsychological testing results is unlikely to be as helpful with similar samples. This issue
is discussed further in the Classification Accuracy section.
Feigning Test Results
Symptom Validity Tests, broadly speaking, were developed to distinguish malingerers from those with genuine pathology. Results for the Test of Memory Malingering
(TOMM), Digit Memory Test (DMT), Letter Memory Test (LMT), Nonverbal Medical
Symptom Validity Test (NV-MSVT), WMS-III WL Inconsistency Index, Miller Forensic
Assessment of Symptoms Test (M-FAST), and CAARS—S:L Inconsistency Index are
provided in Table 3-10, which shows the mean test score for each measure and index.
Cognitive Malingering Measures: Very consistent main effects for group were
demonstrated across all of the cognitive malingering measures (this category excludes the
M-FAST and CAARS—S:L index), except the WMS-II WL Inconsistency Index for
which there was no main effect of group. For those variables with significant main
effects, post-hoc testing indicated that the FGN group consistently scored significantly
lower than the HON group, as well as the ADHD group, which was statistically
equivalent with the HON group. This suggests that the various measures are insensitive to
problems associated with ADHD in undergraduate samples, but are attuned to
performance differences associated with feigning. Indeed, very large effect sizes in the
ADHD-FGN contrast were noted: Excluding the Inconsistency Index, the mean
cognitive feigning measure effect size was g = 1.12. Additionally, the distribution of
FGN and ADHD individual scores was characterized by significantly more FGN than
ADHD individuals producing low scores in each case (see Mann-Whitney p-values). Of
note, examination of the nature of group means shows that for the TOMM and LMT in
particular, more feigners scored in the lower range of effort.
The sensitivity to feigning and specificity for the Honest and ADHD conditions in
contrast to feigning are provided for the cognitive feigning measures in Table 3-11. Near
perfect specificity in the HON vs. FGN contrast was noted across the board at each
measure’s published cut score (examining the best index per measure, M = .982, Med =
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Table 3-10
Feigning Test Results (Mean [SD])
Overall

FGN-ADD

HON
N = 14

FGN
N = 30*

ADHD
N = 29

F

p

U

p

g

Trial 1 % Correct

98.6 (2.98) a

76.7 (13.58) b

93.7 (6.30) a

33.722

.000

109.0

.000

-1.60

Trial 2 % Correct

100.0 (0.00) a

84.5 (17.07) b

99.2 (2.65) a

16.077

.000

147.5

.000

-1.19

Retention % Correct

99.9 (0.54) a

84.9 (16.08) b

99.2 (2.65) a

16.816

.000

120.5

.000

-1.23

DMT % Correct (< 90)

100.0 (0.00) a

90.2 (11.83) b

99.5 (1.30) a

13.634

.000

190.0

.000

-1.10

LMT % Correct (< 93)

100.0 (0.00) a

85.5 (15.97) b

97.7 (3.35) a

13.667

.000

204.5

.001

-1.06

Scale A (< 90)

97.5 (3.25) a

90.5 (9.21) b

97.2 (3.54) a

9.772

.000

215.0

.001

-0.96

Scale B (< 88)

96.3 (4.66) a

87.0 (12.31) b

96.1 (4.73) a

9.855

.000

216.5

.001

-0.97

0.89 (.067)

0.82 (0.108)

0.87 (.091)

2.863

.064

315.5

.070

-0.46

Index (Cut Score)
TOMM Subscales (< 90)
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NV-MSVT

WMS-LL Inconsistency
M-FAST Subscales
RO

.07 (2.67) a

.63 (0.49) b

.34 (0.48) a

7.811

.001

309.5

.028

0.60

ES

.14 (0.36)

.63 (0.96) a

.14 (0.35) b

4.694

.012

313.0

.017

0.68

RC

.00 (0.00)

.53 (1.22)

.21 (0.56)

2.107

.129

390.5

.320

0.33

58

UH

.00 (0.00)

.40 (0.68)

.21 (0.49)

2.811

.067

376.5

.232

0.32

USC

.00 (0.00)

.27 (0.45)

.14 (0.35)

2.667

.076

379.0

.223

0.32

NI

.00 (0.00)

.10 (0.31)

.03 (0.19)

1.101

.338

406.5

.321

0.28

S

.00 (0.00)

.07 (0.25)

.00 (0.00)

1.473

.236

406.0

.161

0.39

TOTAL

.21 (0.58) a

2.63 (3.03) b

1.07 (1.22) a

7.745

.001

292.0

.025

0.67

5.2 (2.25)

5.2 (2.43)

1.436

.245

431.0

.951

-0.22

CAARS Inconsistency

4.0 (2.04)

Note. Within each row, columns with different subscripts are significantly different according to Tukey post-hoc testing, p < .05. *
N = 29 for LMT due to student not finishing protocol before leaving.
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Table 3-11
Frequency of Probable Feigning on Symptom Validity Tests
HON
N = 14

FGN
N = 30*

ADHD
N = 29

Sn to
FGN

Sp for
HON

Sp for
ADHD

Trial 1 (used < 90%)

0

26

5

.867

1.000

.828

Trial 2 (< 90%)

0

14

1

.467

1.000

.966

Retention (< 90%)

0

14

1

.467

1.000

.966

DMT % Correct (< 90%)

0

13

0

.433

1.000

1.000

LMT % Correct (< 93%)

0

15

2

.500

1.000

.931

Scale A (< 90%)

1

14

2

.467

.929

.931

Scale B (< 88%)

2

13

2

.433

.857

.931

M-FAST Total (> 6)

0

3

0

.100

1.000

1.000

CAARS Inconsistency (> 8)

1

5

5

.167

.929

.828

Index (Published Cut Score)
TOMM Subscales

NV-MSVT

Note. WMS-III WL not included because no cut score has been suggested or become
apparent yet. n/a = not applicable due to lack of published cut score; ns = not
significant, * = for LMT, FGN N = 29 due to one student having to leave before protocol
complete.
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1.000). Thus, the cognitive feigning measures are highly unlikely to misclassify a normal
honest undergraduate performing to the best of his/her ability as feigning. Very high
specificity was also noted for the ADHD vs FGN contrast (examining the best index per
measure, M = .946, Med = .926). This suggests that none of these measures is likely to
misclassify ADHD individuals as feigners. The DMT demonstrated the highest Sp (1.0),
followed by TOMM Trial 2 and Retention (both Sp = .966).
While these measures were not developed to identify feigned ADHD or normed
on ADHD samples to develop optimal cut scores, modest sensitivity was noted across the
board (M = .567, Mdn = .484). When a cut score of less than 90% was applied to the
TOMM Trial 1, it far outperformed the other indices with high sensitivity (.867), though
with an accompanying lower specificity (.828). Because of the near-perfect specificity
described above, high accuracy can be expected when an individual is said to be feigning
by any measures except the TOMM T1.
M-FAST: The psychiatric feigning measure performance was characterized by a
very low item endorsement rate for all groups. However, looking at the Total Score
mean (Table 3-10), there was a main effect of role due to feigners endorsing more items
than both HON and ADHD participants (per Tukey HSD results). There was likewise a
tendency for feigners to provide a greater number of higher-ranked responses than
ADHD participants (Mann-Whitney results). A moderately high effect size of g = .67
was noted.
As indicated in Table 3-11, the M-FAST demonstrated perfect specificity for both
the HON and ADHD individuals in this sample, indicating that it did not classify any
non-feigners as feigning using the standard cut score of six or more endorsements.
However, it had very low sensitivity—just .100. Despite the high specificity, the MFAST is unlikely to be helpful because of very low sensitivity to feigned ADHD.
CAARS:S—L Inconsistency Index: Because it is embedded in the CAARS:SL,the results of this measure were examined. An Inconsistent profile typically results
from responses that do not consider item content, such as random responses. Due to the
academic nature of the sample, this index was not expected to discriminate FGN and
ADHD groups, so a lack of main effect of group, a low FGN-ADHD effect size
(g = -0.22, Table 3-10), and very low sensitivity to feigning (.121) are not surprising.
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However, HON and ADHD groups’ individual performance on this measure was of
interest. The mean Inconsistency score for these groups ranged from about four to five
items, suggesting that at a cutoff of >8 endorsements, very few if any individuals would
be classified as inconsistent. This is reflected in the high specificity for HON, .929
(Table 3-11) as well as for ADHD, .828, and provides some support for the index’s
construct validity.
Implications and Direction for Symptom Validity Testing Alone: These results
suggest that at the published cutting scores, no one symptom validity measure alone
would be useful for both ruling out feigning in truly honest normal or ADHD evaluees
and correctly identifying malingering in other individuals. Should only symptom validity
tests be used to maximize classification accuracy, the use of two measures may increase
classification accuracy. Here, a measure with maximal specificity could be used first to
ensure Honest individuals are not wrongfully determined to be feigning, followed by a
measure with high sensitivity to feigning, yet still adequate Sp. Using multiple measures
may also lead to incremental increases in sensitivity. Based on the above results, use of
the DMT followed by the TOMM T1 index might be optimal at these cut scores. This is
evaluated in more detail subsequently.
Final Considerations
Classification Accuracy at the Individual Level
Of those individuals said to have a condition of interest by a measure at a given
cut score, the proportion that actually do is represented by the test’s positive predictive
power (PPP). Negative predictive power, conversely, refers to those accurately said to
not have the condition by that test. For attention-related tests, PPP would related to the
diagnosis of ADHD; for feigning tests, it would relate to malingering. Predictive values
calculated in a study are unique to the base rates of the condition(s) of interest (in this
case, both ADHD and FGN), and require adjustment for other base rates. Predictive
powers from this study can be applied only in the determination of ADHD versus faking,
and therefore should only be used when a clinical profile is noted.
Attention Tests: Because the C-CPT did not demonstrate adequate construct
validity through the consistent and overall clinical elevation of scales by ADHD
participants, its predictive power is irrelevant in that determination, and should not be
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considered. For the symptom-report measures, because no guidelines have been
published to date regarding the detection of ADHD in undergraduate populations where
feigning may be a factor, the sample-specific sensitivities may likewise have reduced
construct validity. It is therefore not recommended that they by used on an individual
basis in that determination, at this time. Further research and/or adjustment of cut scores
is necessary.
Symptom Validity Tests: Due to the high specificity of these measures, high
Positive Predictive Power can be expected such that individuals said to be feigning are
highly likely to have been accurately classified. Indeed, the mean PPP was .904, and was
perfect for the DMT (1.0) and lowest for the TOMM T1 (.863). Because of lower
sensitivities, however, only moderate negative predictive values can be expected. Not
surprisingly, at published cutting scores of feigning measures, a mean NPP of .483 was
observed for the cognitive feigning indices alone. This was highest for the TOMM T1
(.866) and lowest for the NV-MSVT Scale A (.636). As the proportion of malingerers
falls from the approximately 50% base rate in this sample, NPP will increase and PPP
will decrease.
Identifying an Optimal Combination of Predictors
Binary logistic regression can be used to identify, in an exploratory manner, the
optimal combination of tests for predicting feigning versus ADHD status. As previously
stated, it would be ideal to have a series of measures that first identify ADHD individuals
with high sensitivity to the disorder, then rule out feigning with high specificity, and then
identify feigners with high sensitivity to that behavior. The lack of ADHD-sensitive
measures in this population precludes that. Instead, we can only examine the feigning
measures for the best “predictors.”
Two logistic regression models were undertaken. In the first, the predictor
variables examined were the classification status of “probably feigning” or “probably
honest,” assigned at the published cut score of each feigning measure. The second model
examined instead the continuous, raw test data for those measures examined in Model 1.
Both models tested the accuracy of classifying individuals as ADHD or FGN-role.
Model 2 was examined as it is unclear how optimal the published cut scores are for this
sample of educated, high-functioning individuals. Because little to no research exists on
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the use of this study’s measures in the distinction of ADHD vs. feigning for undergraduates, the forward conditional method of data entry was used. Here, all variables are
made available for entry and the statistical software identifies the single best predictor,
and then it identifies subsequent predictors that add significant incremental predictive
power above the first. When measures such as the TOMM had multiple indices, the best
predictor of FGN vs. ADHD status was selected according to AUC values obtained in
ROC analyses. These included the TOMM T1 (using a 90% cut score for Model 1), the
DMT, LMT, MSVT Scale A, and M-FAST. The WMS-III Inconsistency Index, as it
does not have a published cut score, could only be evaluated in Model 2.
Model 1: Results (depicted in Table 3-12) indicate an overall significant model
for the dichotomous variables (χ2 (5, N=58) = 31.698, p = .000), in which 86.2% of
individuals were accurately classified (Nagelkerke R-square = .660). In Step 1, the
TOMM T1 was entered as a single best predictor (β = 3.401, SE = .729, p = .000),
correctly classifying 84.5% of individuals. The final Step 2 entered the DMT, which
added incremental predictive power (change p = .010) when applied after the TOMM,
raising the classification accuracy to its final 86.2%. However, it must be noted that
both the LMT and MSVT Scale A were quite comparable to the DMT (change p = .013
and .026, respectively), so it is not safe to say that this model would hold up when
retested on another sample. In other words, the LMT or MSVT Scale A may be
appropriate secondary measures at their published scores.
Model 2: Results (depicted in Table 3-13) likewise indicate an overall significant
model for the raw data (χ2 (6, N=58) = 24.318, p = .000), also correctly classifying
precisely 86.2% of FGN and ADHD participants (Nagelkerke R-square = .703). Here,
however, while Step 1 similarly entered the TOMM T1 (β = -.174, SE = .045, p = .000),
and Step 2 the DMT (β = -.404, SE = .190, p = .034), a third step was included to add
incremental predictive accuracy via the M-FAST (change p = .034).
Understanding Feigning Strategies
The feigners in this study, simply coached on symptoms, asked not to be too
obvious, and reminded to do at least as “well” or “similar” as someone who would gain
admission to a university, reported only mediocre confidence in their performance (M =
3.3, SD = .80 on a five-point Likert with five being “completely successful”), despite
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Table 3-12
Binary Logistic Regression Analysis for Predicting FGN vs. ADHD Status from Cognitive and
Psychiatric Feigning Tests’ Classification as Probably Feigning or Probably Honest
95% CI for exp b
β (SE)

Lower

exp b

Upper

Classification
Rate

3.401 (.729)***

7.186

30.000

125.250

84.5%

3.109 (.804)***

4.633

22.400

108.298

21.076 (10921.517)

.000

.000

-

Step 1
TOMM T1 class
Step 2
TOMM T1 class
DMT class

86.2%

Note. Forward Stepwise Conditional Logistic Regression was used due to the pilot nature of
these data. Step One entered the observed classification for the following symptom validity
measure to predict FGN or ADHD role: TOMM T1, DMT, LMT, NV-MSVT A, M-FAST. The
overall model was significant, χ2(5, N=58) = 31.698, p = .000. The DMT and LMT were very
similar, p = .010 and .013, respectively. ***=p < .001; Class = probably honest or probably
feigning classification according to published cut score; SE = Standard Error; CI = confidence
Interval. R2 = .660 (Nagelkerke), .495 (Cox & Snell). Model Chi-square(5) = 31.698, p < .001.
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Table 3-13
Binary Logistic Regression Analysis for Predicting FGN vs. ADHD Status from Cognitive and
Psychiatric Feigning Test Scores
95% CI for exp b
β (SE)

Lower

exp b

Upper

Classification
Rate

-.174 (.045)***

.769

.840

.918

79.3%

-.175 (.055)***

.754

.840

.934

-.404 (.190)*

.460

.668

.970

TOMM T1 pr

-.168 (.056)**

.758

.846

.944

DMT pr

-.491 (.218)*

.400

.612

.938

.447 (.267)

.926

1.563

2.639

Step 1
TOMM T1 pr
Step 2
TOMM T1 pr
DMT pr

84.5%

Step 3

M-FAST tot

86.2%

Note. Forward Stepwise Conditional Logistic Regression was used due to the pilot nature of these
data. Step One entered the raw score for the following symptom validity measure to predict FGN
or ADHD role: TOMM T1, DMT, LMT, NV-MSVT A, M-FAST, and WMS-III Inconsistency
Index. M-FAST significance of the change = .034. The overall model was significant, χ2(6,
N=58) = 24.318, p = .000. *** = p < .001, ** = p < .01, *= p < .05; pr = percent correct; tot =
total score; SE = Standard Error; CI = confidence Interval. R2 = .703 (Nagelkerke), .527 (Cox &
Snell).
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their success as a group. Knowledge of how the undergraduate students in this sample
feigned the disorder when fiscally motivated might be helpful for refining existing and
creating new detection strategies.
Self-Reported Feigning Strategies: Table 3-14 presents the self-reported
strategies provided by malingering-role students. Because this was the last question in
the protocol, few responded with notable detail or took time to thoughtfully respond.
These are provided for descriptive purposes only as some students listed several
strategies within multiple categories and others, just a few. As illustrated in the table,
students were about equally likely to list strategies involving physical behavior (despite
being told this was unnecessary), learning style, and response style. Examples of
physical strategies including fidgeting, looking around, and responding slowly. Students
endorsing altering their learning style most often stated that they tried not to concentrate
or pay attention, such as when learning items to memorize. With regard to response
style, a number of students reported deliberately choosing the wrong answer; though
surprisingly, only a few mentioned endorsing ADHD-like symptoms on the symptom
report measures.
Assessment of Feigning Strategy on ADHD-“Diagnostic” Testing: Feigning
strategy for these measures is described by the number of symptoms endorsed and the
specific ADHD subtypes obtained. The FGN group was exceptionally successful in
faking the ARS Current and Childhood Symptoms scales. Figure 1 shows that Current
specific ADHD subtypes obtained. The FGN group was exceptionally successful in
Symptom endorsements resulted in frequencies of Combined, Inattentive, and
Hyperactive-Impulsive subtype specifications that were virtually identical to those of the
ADHD group. These results suggest that a sizable proportion of university students
avoided the “blanket endorsement” strategy for Current Symptoms (though this was more
common for Childhood Symptoms, Figure 2), and that students were more likely to view
the disorder as characterized by inattention than hyperactivity at this age.
On the CAARS—S:L, FGN participants tended to clinically elevate either 2-3 or
6-8 subscales, while ADHD participants demonstrated a parabolic incline in the number
of subscales clinically elevated (0-1, 2-3, 4-5, or 6-8). This may illustrate two different
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Table 3-14
Reported Feigning Strategies
Frequency
(N = 26)

Strategy / Examples
Reference to physical behavior strategy*

14

General reference (e.g., “physical mannerisms”

4

Fidget

3

Look away / look around, not look at items to memorize

3

Be dazed / “daydreamy” / less alert

3

Respond [at a] slow [rate]

2

Act frustrated /look uncomfortable with easy items

2

Make no eye contact

1

Reference to learning strategy

15

Not concentrate / pay attention / focus

12

Try not to memorize / remember / learn

3

Not look at [stimulus items]

3

Not pay attention to instructions, specifically

2

Ignore details

1

Reference to response strategy

17

Indicated deliberate errors

12

Æ Made reference to placement or spread of errors

(3)

Æ Reference to controlling or reducing number of errors

(3)

Æ Only pick wrong answer when it was close

(1)

Respond with regard to ADHD symptoms / be dishonest about symptoms

2

Respond [at a] slow [rate]

2

Guess [between available answers, rather than thinking]

1

Note. Some students provided responses in multiple categories, or multiple responses within one
category. Values in bold Values in parentheses represent components of the above category.
* = Students were told that they did not need to physically act as if they had ADHD.
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20

FGN
ADHD

Count

15

10

5

0
Nonclinical

Inattentive

Hyperactive

Combined

ARS Current Symptom Classifications

69

25

FGN
ADHD

20

Count

15

10

5

0
Nonclinical

Inattentive

Hyperactive

Combined

ARS Childhood Symptom Classifications
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feigning strategies. Because the CAARS—S:L does not lend to subtype identification,
FGN-ADHD patterns were not examined.
Omissions (misses), commissions (false positives), perseverations, and hit rate
(response speed) were examined as potential faking strategies for the C-CPT. Feigners
were successful in their use of perseveration and response rate only: Results reflect that a
relatively similar proportion of feigners and ADHD participants obtained clinically
notable levels of perseverations (43.3% for FGN versus 31.0% for ADHD). Also, the
proportion of FGN participants achieving altered response rates was equivalent to that of
the ADHD group (76.7% versus 75.9%). Of note, those feigners who altered their hit
rate responded faster than normal in 65.2% of cases; this was true for 68.2% of ADHD
participants. FGN-role participants only marginally matched ADHD participants in their
use of false positive errors (with 73.3%, versus 55.2%, respectively having noteworthy
numbers of these). Feigners were least successful with their use of misses (60.0% versus
31.0% clinically noteworthy).

Copyright © Myriam J. Sollman 2008
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Chapter Four: Discussion
A number of motivators exist at the university level for students to seek diagnosis
of ADHD, regardless of whether or not they truly believe they have the disorder. While
research shows that symptoms of ADHD may remit with age (Shaw, 2002; Farone,
Biederman, & Mick, 2006; Biederman et al., 1996), and that impaired students may have
difficulty advancing to higher education (see Barkley & Murphy, 2006) evidence
explored earlier also suggests that there has been a disproportionate increase in ADHDbased claims in higher education in recent years. Unfortunately, little research exists on
how to separate genuine from feigned ADHD symptoms presented by an educated young
adult population. Results from studies on malingering in neurocognitive impairment
groups cannot automatically be expected to generalize to these individuals.
This study evaluated the efficacy of various attention-related, neuropsychological,
and symptom validity measures in the detection of feigned ADHD in an undergraduate
sample. Performance was compared between a group of presumed normal students
(HON), a group of diagnostically “clean” ADHD students asked to respond to the best of
their ability (ADHD), and a group of motivated, coached feigners (FGN). Feigners were
educated about symptoms and characteristics of ADHD, provided with a scenario to help
them relate to the plight of a student would might seek diagnosis, asked not to fake too
obviously (by performing at least as well as a college student would), and provided with
a significant monetary incentive for “successful feigning” ($45). They were not
forewarned about the specific types of tests they would take, nor alerted to the presence
of malingering detection instruments.
This study provides novel results, as little research exists on the susceptibility of
attention-related, neuropsychological, and symptom validity measures to feigned ADHD
in undergraduate samples. Because of the higher cognitive ability of college students and
the poorly understood difficulties posed by ADHD undergraduates, it could not be
assumed that all of these measures would be appropriate. Not surprisingly, results
illustrated that the ADHD symptom-report measures, though sensitive to ADHD, were
quite susceptible to faking. The ARS was successfully faked in 80% of cases (according
to the 1996 norms) and the CAARS—S:L in 67% of cases (when using a stringent cut
score of 4 or more clinical scale elevations). Students did not take a blanket feigning
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strategy by endorsing all symptoms on the measures; instead, the proportion of
individuals achieving Combined subtype, Inattentive Subtype, and Hyperactive Subtypes
closely matched that of the ADHD group. The Conners CPT, in contrast to those
measures, had both limited sensitivity to ADHD and specificity for FGN in this sample.
Only about 24% of ADHD students were consistently identified by published cut scores,
and slightly less than 50% of FGN-role participants obtained clinically elevated results.
A selection of neuropsychological tools validated to assess attention,
concentration, memory, and reading speed, including the Stroop task (Golden &
Freshwater, 1999), Nelson-Denney Comprehension Test Reading Speed component, and
the WMS-III Word Lists subscale, likewise had limited utility in separating ADHD from
HON groups. Evidence from these measures suggests that the admonished feigners
obtained only slightly depressed scores, but enough so that their performance as a group
was worse than that of the HON group. Only the Stroop Word subscale had FGN-ADHD
differences, and the measures generally did not have HON-ADHD differences due to
comparable reading speeds and list learning abilities. Thus, the chosen battery of
neuropsychological measures may have limited utility in the identification of genuine
ADHD symptoms and feigned presentations.
At their published cutting scores, several neurocognitive feigning measures
demonstrated strong specificity, with large AUCs illustrating good classification at the
range of cutting scores. ADHD participants were very unlikely to be misclassified as
feigners by these measures, so when applied to clinical evaluations of like samples,
reasonable accuracy might be expected for those who were identified as feigners. The
TOMM Trial 1 demonstrated the highest sensitivity, and was the only measure with
adequate sensitivity to detect feigning at cutting scores employed. However, its
corresponding specificity was below 90%. Moreover, this index has only infrequently
been recommended for use in screening for feigning (see Sarmra, 2004; Bauer, O’Bryant,
Lynch, McCaffrey, & Fisher, 2007; O’Bryant, Engel, Kleiner, Vasterling, & Black, 2007;
Gavett, O’Bryant, Fisher, & McCaffrey, 2005). In the present study, binary logistic
regression using various feigning test results (Honest or Probable Feigning) identified the
TOMM T1 followed by the DMT as strong predictors in combination. The LMT and
M-FAST demonstrated incremental predictive ability closely matching the DMT in the
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present sample.
It was hoped that a three-step classification procedure, where ADHD is identified
with a highly sensitive test (or series of measures) in the first step, feigning is ruled out
with a highly specific symptom validity tool in the second step, and probable feigning is
identified with more sensitive malingering tests in the third step, would be identified.
However, such did not emerge from these data. At this time, it is necessary to be reliant
on clinicians’ use of sound diagnostic procedures to arrive at a confident “pre-diagnosis”
of ADHD. These include a detailed clinical interview, corroborating interview (for
historical information and evidence of dysfunction), neuropsychological and
psychological testing (to rule out all alternate cognitive and psychiatric conditions), and
an evaluation of possible incentives for feigning. Fortunately, the present data indicate
that there exist at least two strong, easily administered measures—the TOMM and the
DMT—against which the classification accuracy of a pre-diagnosis of ADHD can be
assessed relative to feigning.
Two major limitations exist in this study: the first lies in the nature of the research
design, the second, in the nature of the clinical group. As both a pilot study and a
simulation design, generalizability of the data is limited, and cross-validation in multiple
university or college settings and geographical regions is necessary. Because no “gold
standard” exists to identify either genuine ADHD or feigned ADHD in this population,
researchers must rely on the analog methodology at this time.
Regarding the clinical sample used, a few points must be noted. First, diagnostic
accuracy of the ADHD group could not feasibly be perfect. Clinicians undoubtedly vary
in their approach to diagnosing the disorder, as well as the base rate at which they apply
it. To assess the likelihood that each student’s diagnosis was accurate, ADHD
participants were phoned 3-15 months after their participation. Each was told that “some
psychologists or psychiatrists may diagnose the disorder when they are not 100% certain
the individual has it, as many conditions share symptoms with ADHD,” and then asked to
rate the confidence they had that the diagnosis pertained to them on a scale of 1 to 10,
with 10 being absolutely confident. Nineteen students were reached, but one provided a
rating of “five, chance” because he believed that “ADHD is a made-up condition.” This
student’s results were excluded. The remaining had a mean rating of 9.2 (SD = 1.00),
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reflecting high certainty that they had ADHD, and not another condition with similar
symptoms. Anecdotally, the data of two students who provided responses of complete
certainty had been excluded from analysis for failure to produce clinical profiles on the
ADHD-specific tests.
Another concern regarding the clinical group is that performance was obtained
from ADHD students without known comorbid diagnoses. Though this may have
increased diagnostic certainty to some extent, application of these results to students with
greater pathology should not be assumed until more data are available. In addition,
substance use of the ADHD group was not evaluated to rule out the influence of this on
symptoms reported. Second, and related, without independent evaluation of the ADHD
condition for each participant before inclusion, the clinical standing of each participant
cannot be verified. Accuracy was maximized by ruling out participants with comorbid
diagnoses and omitting those students who failed to present current symptoms of ADHD
(N = 4).
Additional research is needed in this field in order to identify measures or to recalibrate scoring methods in order to accurately identify ADHD as disordered university
undergraduates experience it. Evidence suggests that adults seeking first diagnosis, and
adults who were diagnosed during childhood, experience ADHD differently than children
do (see Barkley, Murphy, & Fischer, 2008). Moreover, further research is necessary to
identify procedures that rule out suboptimal effort and altered self-presentation, within
the young adult population. Evaluations should not be limited to the measures explored
in this study. With more research, adjustment of cutting scores in existing measures may
prove useful. A focus on maximizing specificity for “honesty” before then identifying
measures sensitive to feigning, is recommended. Comparing the forced-choice methods
employed in this study, it appears that both face validity and actual difficulty may have
played a role in the accuracy of these measures, particularly the LMT and DMT. It will
be necessary to obtain further information on the performance of the most successful
index in this population—TOMM Trial 1—as well as to develop additional measures to
maintain the advantage over bright, motivated students.

Copyright © Myriam J. Sollman 2008
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Appendix A. Mass Screening Form.

Student ID: __ __ __ __ __

Some research opportunities are available for individuals who have been diagnosed with,
or without, certain disorders.

Do you presently have a diagnosis of:
ADD or ADHD
An anxiety disorder
A depressive disorder
A thought disorder
A learning disability

Yes / No
Yes / No
Yes / No
Yes / No
Yes / No

Have you ever been knocked unconscious?

Yes / No
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Paid Research Study
333-xxxx

Paid Research Study
333-xxxx

Paid Research Study
333-xxxx

Paid Research Study
333-xxxx

Paid Research Study
333-xxxx

Paid Research Study
333-xxxx

Paid Research Study
333-xxxx

Paid Research Study
333-xxxx

Paid Research Study
333-xxxx

Paid Research Study
333-xxxx

Paid Research Study
333-xxxx

Paid Research Study
333-xxxx

Paid Research Study
333-xxxx

Paid Research Study
333-xxxx

Appendix B. Clinical Participant Recruitment Flier

Attention UK Undergraduates:
Do you have
Attention Deficit Disorder?
(ADD or ADHD)
If so, you can make $45
by participating in a research study.

We would like to see how effective
various tests are at diagnosing ADHD
in college students.

please call for more information:
Myriam
(859) XXX-XXXX

Appendix C. Phone Screening Form for Non-Clinical Undergraduates
SAY: My name is __ and I'm calling from the Department of Psychology. I'm contacting you because
you completed the Introductory Psychology mass screening session and indicated interest in a research
study for Introductory Psychology research credits. I have a 2-credit study. Do you still need research
credits at this time? (if Yes): Great! I'd like to tell you more about the study, but first I need to get some
general information to see
if you qualify. Only your first name and phone number will be associated with the information you provide,
if
you tell me at the end of this call that you are still interested. Ok?
1. How old are you?____________________________
2. What year are you?

F

So

Jr

Sr

Other: (_____ th

semester)

3. What is your first language: ___________________
4. This is a study about ADHD. We have openings for people with and without ADHD. Have you been
diagnosed with ADHD?
Yes
No
If yes, complete ADHD Group phone screening tool.
5. We also have openings for people with and without an anxiety disorder. Have you been diagnosed with
an anxiety disorder?
Yes
No
6. How about a learning disability? Yes

No

7. Have you been diagnosed with any other psychological, psychiatric, or neurological disorders?
_______________________________________________________________________
SAY: Thank you very much for answering these questions. Now let me tell you more about the study. This
study involves you taking a number of different tests that are used to diagnose ADHD. We are interested in
whether these tests can discriminate between people with ADHD people without its. The tests are all
pencil /
paper, verbal, or computerized. If you participate, it will take about two hours of your time and you will be
compensated 2 research credits.
Are you still interested in participating?
If yes: collect contact info
8. First name__________________
F

If No: stop (circle)
Phone_________________

9. Gender:

M

Thank you. I will give this information to the lead investigator in charge of this study and she will contact
you within one month to schedule an appointment if you meet criteria.
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Appendix D. Phone Screening Form for ADHD Participants.
SAY: Hi. My name is Myriam Sollman and I'm calling from the Department of Psychology regarding an
ADHD research study.
THEN EITHER:
-I received your message about participating in the study. Thank you for calling!
-I'm calling because you completed the Introductory Psychology Mass Screening Questionnaire and
indicated an interested in participating in research studies. I have a 2-credit study. Do you still need
credits? [If yes]: Great! Thank you for your interest in this study.
THEN:
I need about 5 minutes of your time to tell you a little about the study, and ask some questions to see if you
qualify for this study. Is this a good time for you?
THEN:
This is a study about the ability of some tests to properly diagnose people who do or do not have ADHD. If
you qualify and are interested in participating, it takes about 2 hours and pays $45 [if applicable, as well
as 2 Intro Psyc research credits]. I need to ask you some more questions, some of which may seem
personal. However, only your first name and phone number will be associated with the answers if at the
end of this call you state that you are interested in participating. Also, only I, a PhD student in the
Department of Psychology, will have access to your responses.
1. Where did you see this ad?_____________________
2. How old are you?____________

3. Are you a UK student?_________________

4. What year?

Jr

F

So

Sr

Other: (_____ th

semester)

5. What is your first language?___________________
6. As you know, this is a study about ADHD. We have openings for people with and without ADHD.
Have you been diagnosed with ADHD?
Yes
No
If No, collect contact info and tell individual that we will call them to schedule if they meet criteria. If
Yes, continue….
7. I'd like to ask you more about that.
a. When were you diagnosed (age/grade/year?)_____________________________________
b. What sort of health care professional gave you this diagnosis?
GP
psychiatrist
psychologist
neuropsychologist
DK
or
PhD
MD
8. Now I'd like to ask you about the process you went through to get diagnosed.
a. Did you take any tests?
Yes
No
(If yes): What sorts of tests
__
pencil / paper that asked about your symptoms
__
pencil / paper not asking specifically about symptoms
__
Computerized
b. Did your parent or guardian fill out any questionnaires?
Yes
No
c. Do you remember how long this evaluation took? Was it one appointment, more?
_________________________________________________________________________
c. Was there someone who came into the classroom to observe you?
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Yes

No

Appendix D cont.
9. Do you have access to a diagnostic report or evaluation?
No

Yes

10. Are you taking medication for this right now?
No
(If yes): ____________________

Yes

11. About how often do you skip a dose, either accidentally or on purpose? _________________
12. We have different opportunities for people in this study. One involves not taking medication for about
12 hours before your participation, so that we can know how people with ADHD do without treatment.
Would you be interested in doing this? I would work around your school schedule, and can test on a
Saturday if you prefer.
Yes
No
13. Another opportunity is for people who have been diagnosed with other disorders. Do you currently
have a diagnosis of a learning disability?
Yes
No
14. How about any mood, anxiety, or thought disorder?
No

Yes

14. How about any other psychiatric, psychological, or neurological disorder?
No

Yes

SAY: Thank you for answering these questions. Now let me tell you more about the study. This study
involves you taking a number of different tests that are used to diagnose ADHD. Some of them, you may
have taken before. These are all pencil / paper, or computerized tests. If you qualify and participate, it
will take about two hours of your time and you will be compensated $45. The study is conducted at Kastle
Hall on UK's campus.
If you qualify for enrollment, would you like to participate?
If Yes:

If No: Stop (circle no)

14. First name__________________

Phone_____________________

15. Gender:

M

F

Thank you. I will have to determine if you meet criteria. If you do, I will call you to schedule your
appointment within the next month.
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Appendix E. Demographic Questionnaire
INSTRUCTIONS: Please respond to the following as best you can. You do not need to share your
responses with the examiner. Your responses will NOT be associated with your name. Please put this in
the envelope and seal it when done.
Gender: M

F

Age: _______________
Handedness:

R

L

Ethnic background:
African American
Asian/Pacific Islander
Education:

Freshman

Hispanic/Latino
Caucasian
Sophomore

Junior

Senior

Native American
Other______________________
Other _________________________

Please check which apply to you. If you respond "Yes," please answer the Additional questions below:
1. Color Blindness

N

Y

2. Repeated a Grade

N

Y

3. Knocked Unconscious

N

Y

(respond for most severe occurrence)
Length of Time: Unconscious________
Age of occurrence: _________
4. Attention Deficit Disorder

N

Hospitalized_________
Do you remember this happening?_______

Y

Type: ___________________________
Age diagnosed:________
What medication do you take for this?__________________________
Have you taken medication for this in the past 12 hours?
Y/N
5. Learning Disability

N

Type: _____________________
6. Current Mood, Anxiety,
or Thought Disorder

N

(list separately)
Type: ____________________
Type: ____________________
Type: ____________________
7. Neurological or Neurodegenerative Disorder

N

(list separately)
Type: ___________________
Type: ___________________

Y
Age diagnosed:________
Y
Age diagnosed:___
Age diagnosed:___
Age diagnosed:___

Are you currently being treated? Y / N
Are you currently being treated? Y / N
Are you currently being treated? Y / N

Y
Age diagnosed:___
Age diagnosed:___

Are you currently being treated? Y /N
Are you currently being treated? Y /N

Thank you! Please seal this in the envelope provided.
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Appendix F. Packet Given to Faking Group
Faking ADHD
While faking ADHD, it may help you to pretend that this scenario applies to you:
Your roommate has been diagnosed with ADHD. S/he had trouble with classes, but then
was given some medication for ADHD, and now does well. S/he even got a couple of
A's recently, and has more time to socialize because studying is not as hard! During
your midterms, you decided to try your roommate's medication, and ended up surprising
yourself with how much easier things went. You may think that you have undiagnosed
ADHD, so you "Google" the disorder to learn more about it. On the following pages are
some of the things that you find.
Feel free to underline or write notes on these pages. At the end of the internet information,
you will be asked to jot down a few symptoms or characteristics of people with ADHD to
help you fake.
Website 1
Address

http://www.daytrana.com/?SOURCE=GOOG&KEYWORD=p

WHAT ARE THE SYMPTOMS OF ADHD?
•

The most common behaviors exhibited by those who have ADHD are inattention,
hyperactivity, and impulsivity. People with ADHD often have difficulty focusing, are
easily distracted, have trouble staying still, and frequently are unable to control their
impulsive behavior.

•

Because everyone shows signs of these behaviors at times, the DSM-IV-TR specifies that
the behaviors must appear early in life (before age 7) and continue for at least six months.

•

In children, these behaviors must be more frequent or severe than in other children the
same age. In addition, the behaviors must interfere with at least two areas of a person’s
life, such as paying attention in school, completing homework, or making friends.

•

ADHD in adults looks much as it does in children, except that much less hyperactivity is
present. Still, inattention and impulsivity can have a major effect on functioning at work
and in social relationships. People often have difficulty focusing, are easily distracted,
have trouble staying still, and frequently are unable to control their impulsive behavior.

1
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Appendix F cont.
Website 2
Address

http://www.adultADHD.com/2_2_recognizing/2_2_recognizing.jsp

Recognizing Adult ADHD
Fidgeting, interrupting conversations, losing things, forgetting the reason for a trip
to the grocery store – everyone acts this way once in a while. But a long and persistent
history of restless, impulsive, or inattentive behavior may be a sign of Adult ADHD.
This is especially true if these behaviors have existed since childhood and result in
problems at work, home, and/or in social situations.
If you think you may have Adult ADHD, here are several questions you may want to
ask yourself. These are some of the questions that can help doctors and healthcare
professionals screen for Adult ADHD.
Ask yourself these questions and think about how long you have experienced these
symptoms and how often they occur. If these symptoms are interfering with your
success at home, at work or with friends, you may want to talk with your doctor or
healthcare professional about a clinical evaluation.
•
•
•
•
•
•
•
•

Do you have difficulty concentrating or focusing your attention on one thing?
Do you often start multiple projects at the same time, but rarely finish them?
Do you have trouble with organization?
Do you procrastinate on projects that take a lot of attention to detail?
Do you have problems remembering appointments or obligations?
Do you have trouble staying seated during meetings or other activities?
Are you restless or fidgety?
Do you often lose or misplace things?

2
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Appendix F cont.
Research Participant: On the next two pages are diagnostic screening tests you find. Please read
through the questions. You do not need to complete the tests.
Website 3
Address

http://www.adultADHD.com/2_2_recognizing/2_2_recognizing.jsp

Screener Test
Many adults have been living with Adult Attention-Deficit Disorder (Adult ADHD) and
don't recognize it. Why? Because its symptoms are often mistaken for a stressful life. If
you've felt this type of frustration most of your life, you may have Adult ADHD; a
condition your doctor can help diagnose and treat.

Adult Self-Report Scale (ASRS – V1.1) Screener
from WHO Composite International Diagnostic Interview

How often do you have trouble wrapping up the final details of a
project, once the challenging parts have been done?

Never
Rarely
Sometimes
Often
Very Often

© World Health Organization

◘ ◘ ◘ ◘ ◘

How often do you have difficulty getting things in order when
you have to do a task that requires organization?

◘ ◘ ◘ ◘ ◘

How often do you have problems remembering appointments
or obligations?

◘ ◘ ◘ ◘ ◘

When you have a task that requires a lot of thought, how
often do you avoid or delay getting started?

◘ ◘ ◘ ◘ ◘

How often do you fidget or squirm with your hands or
your feet when you have to sit down for a long time?

◘ ◘ ◘ ◘ ◘

How often do you feel overly active and compelled to do things,
like you were driven by a motor?

◘ ◘ ◘ ◘ ◘

3
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Appendix F cont
Website 4
Address

http://psychcentral.com/ADHDquiz.htm

Adult ADD/ADHD Test
Jasper/Goldberg Adult ADHD Screening Quiz
by Larry Jasper & Ivan Goldberg
Instructions: The 24 items below refer to how you have behaved and felt DURING MOST OF
YOUR ADULT LIFE. If you have usually been one way and recently have changed, your
responses should reflect HOW YOU HAVE USUALLY BEEN. For each item, indicate the
extent to which it is true by checking the appropriate box next to the item.

1. At home, work, or school, I find my mind wandering from tasks that are uninteresting or
difficult.
2. I find it difficult to read written material unless it is very interesting or very easy.
3. Especially in groups, I find it hard to stay focused on what is being said in conversations.
4. I have a quick temper... a short fuse.
5. I am irritable, and get upset by minor annoyances.
6. I say things without thinking, and later regret having said them.
7. I make quick decisions without thinking enough about their possible bad results.
8. My relationships with people are made difficult by my tendency to talk first and think later.
9. My moods have highs and lows.
10. I have trouble planning in what order to do a series of tasks or activities.
11. I easily become upset.
12. I seem to be thin skinned and many things upset me.
13. I almost always am on the go.
14. I am more comfortable when moving than when sitting still.
15. In conversations, I start to answer questions before the questions have been fully asked.
16. I usually work on more than one project at a time, and fail to finish many of them.
17. There is a lot of "static" or "chatter" in my head.
18. Even when sitting quietly, I am usually moving my hands or feet.
19. In group activities it is hard for me to wait my turn.
20. My mind gets so cluttered that it is hard for it to function.
21. My thoughts bounce around as if my mind is a pinball machine.
22. My brain feels as if it is a television set with all the channels going at once.
23. I am unable to stop daydreaming.
24. I am distressed by the disorganized way my brain works.

Research participant: When you are done reviewing these materials, please use the colored
paper to jot down symptoms that will help you remember how to fake on the tests you will be
given. Tell the examiner when you are done.
4
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Appendix G. Debriefing Form

Debriefing Form: Faking Group
Thank you for participating in our study! As we told you in the beginning, the purpose of this
study is to determine how effectively some tests discriminate between individuals with true
ADHD and individuals asked to fake ADHD.
In order to motivate you to fulfill your role as well as you could, we offered that you would
receive a "bonus incentive" if you followed instructions and were successful in your role. In
reality, everyone is given this incentive.
We ask that you do not discuss this with anyone. If others know how the study is run, then we
will not get the effort and motivation from participants necessary for us to determine if these
tests really work! This is an important study that can bring the University of Kentucky much
recognition if it is run properly, so please do not discuss what you did with anyone!
If you do not wish to have your data included, please tell the examiner now.
Thank you again for your participation!

I MAINTAIN CONSENT / WITHDRAW CONSENT to have my data used in this study.
(circle one)

______________________________
Print Name
Date

_____________________________
Witness
Date

_____________________________
Sign Name

______________________________
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Appendix H. Manipulation Check (Post-Testing Questionnaire)

Post-Testing Questionnaire
Please write the instructions (role) you were given at the very beginning of this study:

How well did you understand these instructions given at the very beginning?
___________________________________________________________
1
2
3
4
5
Not at
Perfectly
All
Well

How hard did you try to follow the instructions or role given at the very beginning?
___________________________________________________________
1
2
3
4
5
Not at
Your
All
Hardest

How successful do you think you were at following those instructions or playing the role
given at the very beginning?
___________________________________________________________
1
2
3
4
5
Not at
Somewhat
Extremely
All
Successful
Successful

What was your strategy for this?
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